<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">55911</article-id><article-id pub-id-type="doi">10.7554/eLife.55911</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-182681"><name><surname>Kovalenko</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182682"><name><surname>Erdin</surname><given-names>Serkan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6587-2625</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182683"><name><surname>Andrew</surname><given-names>Marissa A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182687"><name><surname>St Claire</surname><given-names>Jason</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182688"><name><surname>Shaughnessey</surname><given-names>Melissa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182689"><name><surname>Hubert</surname><given-names>Leroy</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182690"><name><surname>Neto</surname><given-names>João Luís</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0863-158X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182704"><name><surname>Stortchevoi</surname><given-names>Alexei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-67523"><name><surname>Fass</surname><given-names>Daniel M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0018-8093</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-182692"><name><surname>Mouro Pinto</surname><given-names>Ricardo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-126262"><name><surname>Haggarty</surname><given-names>Stephen J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7872-168X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-175235"><name><surname>Wilson</surname><given-names>John H</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182694"><name><surname>Talkowski</surname><given-names>Michael E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-125739"><name><surname>Wheeler</surname><given-names>Vanessa C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2619-589X</contrib-id><email>wheeler@helix.mgh.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf4"/></contrib><aff id="aff1"><label>1</label><institution>Center for Genomic Medicine, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Program in Medical and Population Genetics, Broad Institute of MIT and Harvard</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Neurology, Massachusetts General Hospital, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Orr</surname><given-names>Harry T</given-names></name><role>Reviewing Editor</role><aff><institution>University of Minnesota</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Senior Editor</role><aff><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution><country>India</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>29</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e55911</elocation-id><history><date date-type="received" iso-8601-date="2020-04-15"><day>15</day><month>04</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-28"><day>28</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Kovalenko et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Kovalenko et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-55911-v2.pdf"/><abstract><p>Somatic expansion of the Huntington’s disease (HD) CAG repeat drives the rate of a pathogenic process ultimately resulting in neuronal cell death. Although mechanisms of toxicity are poorly delineated, transcriptional dysregulation is a likely contributor. To identify modifiers that act at the level of CAG expansion and/or downstream pathogenic processes, we tested the impact of genetic knockout, in <italic>Htt</italic><sup>Q111</sup> mice, of <italic>Hdac2</italic> or <italic>Hdac3</italic> in medium-spiny striatal neurons that exhibit extensive CAG expansion and exquisite disease vulnerability. Both knockouts moderately attenuated CAG expansion, with <italic>Hdac2</italic> knockout decreasing nuclear huntingtin pathology. <italic>Hdac2</italic> knockout resulted in a substantial transcriptional response that included modification of transcriptional dysregulation elicited by the <italic>Htt</italic><sup>Q111</sup> allele, likely via mechanisms unrelated to instability suppression. Our results identify novel modifiers of different aspects of HD pathogenesis in medium-spiny neurons and highlight a complex relationship between the expanded <italic>Htt</italic> allele and <italic>Hdac2</italic> with implications for targeting transcriptional dysregulation in HD.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>huntington's disease</kwd><kwd>repeat instability</kwd><kwd>histone deacatylase</kwd><kwd>chromatin</kwd><kwd>medium spiny neuron</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009836</institution-id><institution>Huntington Society of Canada</institution></institution-wrap></funding-source><award-id>New Pathways Research Grant</award-id><principal-award-recipient><name><surname>Wheeler</surname><given-names>Vanessa C</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NS049206</award-id><principal-award-recipient><name><surname>Wheeler</surname><given-names>Vanessa C</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000887</institution-id><institution>Huntington's Disease Society of America</institution></institution-wrap></funding-source><award-id>Berman Topper Career Development Award</award-id><principal-award-recipient><name><surname>Mouro Pinto</surname><given-names>Ricardo</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM38219</award-id><principal-award-recipient><name><surname>Wilson</surname><given-names>John H</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>EY11731</award-id><principal-award-recipient><name><surname>Wilson</surname><given-names>John H</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>1F3HG004918</award-id><principal-award-recipient><name><surname>Hubert</surname><given-names>Leroy</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Genetic knockout of Hdac2 modifies molecular and cellular phenotypes in Huntington’s disease mice and has a prominent transcriptional regulatory role in adult medium spiny neurons.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Huntington’s disease (HD) is a dominantly inherited neurodegenerative disorder typically manifesting in midlife with motor, cognitive, and psychiatric symptoms, leading to death after 15–20 years (<xref ref-type="bibr" rid="bib94">Vonsattel et al., 1985</xref>; <xref ref-type="bibr" rid="bib32">Harper, 1999</xref>). HD is caused by the inheritance of an expansion &gt;35 repeats of a polymorphic CAG repeat tract in the <italic>HTT</italic> gene (<xref ref-type="bibr" rid="bib66">Macdonald et al., 1993</xref>), ultimately resulting in cellular dysfunction and death, with medium-spiny neurons (MSNs) of the striatum being exquisitely sensitive to this mutation (<xref ref-type="bibr" rid="bib94">Vonsattel et al., 1985</xref>). The expanded <italic>HTT</italic> CAG repeat undergoes further time-dependent, CAG length-dependent and tissue/cell-type-dependent expansion (<xref ref-type="bibr" rid="bib96">Wheeler et al., 1999</xref>; <xref ref-type="bibr" rid="bib46">Kennedy and Shelbourne, 2000</xref>; <xref ref-type="bibr" rid="bib45">Kennedy et al., 2003</xref>; <xref ref-type="bibr" rid="bib92">Veitch et al., 2007</xref>; <xref ref-type="bibr" rid="bib28">Gonitel et al., 2008</xref>; <xref ref-type="bibr" rid="bib88">Swami et al., 2009</xref>; <xref ref-type="bibr" rid="bib53">Lee et al., 2010</xref>; <xref ref-type="bibr" rid="bib54">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>; <xref ref-type="bibr" rid="bib52">Larson et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Geraerts et al., 2016</xref>; <xref ref-type="bibr" rid="bib2">Ament et al., 2017</xref>; <xref ref-type="bibr" rid="bib76">Mouro Pinto et al., 2020</xref>). The repeat is highly unstable in the brain, particularly in MSNs (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>), with individual-specific differences in the extent of somatic CAG expansion in HD postmortem brain associated with age of onset (<xref ref-type="bibr" rid="bib88">Swami et al., 2009</xref>). Recent genome-wide association studies (GWAS) for modifiers of HD onset highlight somatic CAG expansion as a key driver of the rate of disease onset (<xref ref-type="bibr" rid="bib25">Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium, 2019</xref>). Genetic data from these GWAS as well as extensive cross-tissue analyses of somatic instability (<xref ref-type="bibr" rid="bib76">Mouro Pinto et al., 2020</xref>) support a two-step model of HD pathogenesis whereby cellular vulnerability is determined by both the rate of somatic CAG expansion and a toxic process(es) triggered by somatically expanded repeats. Thus, a comprehensive understanding of HD pathogenesis will necessitate insight into mechanisms underlying both CAG instability and cellular toxicity.</p><p>HD mouse models provide valuable systems in which to identify genetic modifiers. As the two components of the HD pathogenic process outlined above are separable mechanistically, they can be influenced by different modifiers, or by the same modifier via different underlying mechanisms. However, modifiers influencing somatic expansion may also alter downstream phenotypes depending on the sensitivity to detect the impact of altered CAG length. Several DNA repair genes modify somatic CAG expansion in HD mouse models, with mismatch repair (MMR) genes being critical drivers of this process. (<xref ref-type="bibr" rid="bib99">Wheeler et al., 2003</xref>; <xref ref-type="bibr" rid="bib22">Dragileva et al., 2009</xref>; <xref ref-type="bibr" rid="bib90">Tomé et al., 2013</xref>; <xref ref-type="bibr" rid="bib80">Pinto et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Kovtun et al., 2007</xref>; <xref ref-type="bibr" rid="bib72">Mollersen et al., 2012</xref>). Knowledge of additional modifiers in the mouse is likely to shed insight into underlying mechanisms that are currently unknown, or into ways in which the process might be regulated. For example, local chromatin structure has been suggested to influence repeat instability (<xref ref-type="bibr" rid="bib29">Gorbunova et al., 2004</xref>; <xref ref-type="bibr" rid="bib42">Jung and Bonini, 2007</xref>; <xref ref-type="bibr" rid="bib58">Libby et al., 2003</xref>; <xref ref-type="bibr" rid="bib59">Libby et al., 2008</xref>; <xref ref-type="bibr" rid="bib20">Dion et al., 2008</xref>; <xref ref-type="bibr" rid="bib103">Yang and Freudenreich, 2010</xref>; <xref ref-type="bibr" rid="bib77">Nestor and Monckton, 2011</xref>; <xref ref-type="bibr" rid="bib78">Neto et al., 2017</xref>). The precise molecular underpinnings of cellular toxicity also remain to be defined. However, global transcriptional dysregulation and epigenetic alterations have emerged as likely significant contributors to disease pathogenesis (<xref ref-type="bibr" rid="bib27">Glajch and Sadri-Vakili, 2015</xref>; <xref ref-type="bibr" rid="bib85">Sharma and Taliyan, 2015</xref>). There is an extensive history of investigating histone deacetylase (HDAC) inhibitors in HD and several studies have shown beneficial effects in HD mouse models (<xref ref-type="bibr" rid="bib33">Hockly et al., 2003</xref>; <xref ref-type="bibr" rid="bib24">Gardian et al., 2005</xref>; <xref ref-type="bibr" rid="bib89">Thomas et al., 2008</xref>; <xref ref-type="bibr" rid="bib68">Mielcarek et al., 2011</xref>; <xref ref-type="bibr" rid="bib38">Jia et al., 2012a</xref>; <xref ref-type="bibr" rid="bib39">Jia et al., 2012b</xref>; <xref ref-type="bibr" rid="bib40">Jia et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Chopra et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Suelves et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Siebzehnrübl et al., 2018</xref>). Interestingly one study found that a selective HDAC3 inhibitor also reduced CAG expansion in HD mice (<xref ref-type="bibr" rid="bib87">Suelves et al., 2017</xref>).</p><p>Here, with the overarching goal of identifying novel HD modifiers, and with the possibility that epigenetic alterations may contribute both to CAG instability and cellular toxicity processes, we tested the roles of specific histone deacetylases (HDACs) in these different aspects of HD pathogenesis. We have taken a genetic approach using a well-established precise genetic HD knock-in mouse model (<italic>Htt</italic><sup>Q111</sup>) (<xref ref-type="bibr" rid="bib97">Wheeler et al., 2000</xref>) and conditionally deleted either <italic>Hdac2</italic> or <italic>Hdac3</italic>, encoding class I HDACs implicated by previous pharmacological studies, specifically in striatal MSNs. We performed RNA sequencing (RNA-seq) to investigate the impact of MSN-specific <italic>Hdac2</italic> knockout on the transcriptome and on gene expression changes elicited by the <italic>Htt</italic><sup>Q111</sup> allele, and tested the effect of MSN-specific <italic>Hdac2</italic> and <italic>Hdac3</italic> knockout on CAG instability and on nuclear huntingtin pathology, both of which occur selectively in MSNs in these mice (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>; <xref ref-type="bibr" rid="bib97">Wheeler et al., 2000</xref>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>MSN-specific knockout of <italic>Hdac2</italic> and <italic>Hdac3</italic> in <italic>Htt</italic><sup>Q111</sup> knock-in mice</title><p>To investigate the role of HDACs in <italic>Htt</italic><sup>Q111</sup> mice we took a genetic approach, focusing on two Class I HDACs, HDAC2 and HDAC3, due to previous interest in therapeutic targeting of this class of HDACs in HD (<xref ref-type="bibr" rid="bib27">Glajch and Sadri-Vakili, 2015</xref>) and the relatively high expression levels of these HDACs in the striatum and in neurons (<xref ref-type="bibr" rid="bib11">Broide et al., 2007</xref>). As constitutive genetic knockout of <italic>Hdac2</italic> can result in perinatal lethality (<xref ref-type="bibr" rid="bib91">Trivedi et al., 2007</xref>; <xref ref-type="bibr" rid="bib73">Montgomery et al., 2007</xref>), and knockout of <italic>Hdac3</italic> results in early embryonic lethality (<xref ref-type="bibr" rid="bib74">Montgomery et al., 2008</xref>), we took advantage of conditional ‘floxed<italic>’ Hdac2</italic> and <italic>Hdac3</italic> alleles (<xref ref-type="bibr" rid="bib73">Montgomery et al., 2007</xref>; <xref ref-type="bibr" rid="bib74">Montgomery et al., 2008</xref>), and deleted each of these genes in striatal MSNs of heterozygous <italic>Htt</italic><sup>Q111/+</sup> mice in crosses together with ‘DARPP-32 Cre’ (D9-Cre) transgenic mice expressing Cre recombinase under the control of the <italic>Ppp1r1b</italic> gene promoter and regulatory elements from 5 to 6 weeks of age (<xref ref-type="bibr" rid="bib8">Bogush et al., 2005</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). We previously used these mice in a similar strategy to delete the <italic>Msh2</italic> gene in MSNs (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>). We generated <italic>Htt</italic><sup>Q111/+</sup> or <italic>Htt</italic><sup>+/+</sup> mice harboring two floxed <italic>Hdac2</italic> or <italic>Hdac3</italic> alleles together with the D9-Cre transgene, resulting in deletion of the <italic>Hdac2</italic> or <italic>Hdac3</italic> alleles in MSNs (<italic>Hdac2</italic> or <italic>Hdac3</italic> knockout [KO]) and their littermates expressing both <italic>Hdac2</italic> or <italic>Hdac3</italic> alleles (<italic>Hdac2</italic> WT or <italic>Hdac3</italic> WT). HDAC2 or HDAC3 protein are no longer detectable in the majority of the striatal cells in <italic>Hdac2</italic> KO or <italic>Hdac3</italic> KO mice (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The remaining HDAC2- or HDAC3-immunopositive cells are DARPP-32 negative, reflecting continued expression in cell types other than MSNs in the striatum (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Western blots also confirmed the loss of HDAC2 protein in striata from <italic>Hdac2</italic> KO mice and revealed a compensatory increase in HDAC1 protein levels as seen in other systems with long-term loss of HDAC2 (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). As expected, HDAC2 and HDAC3 expression were not altered in the cortex (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Whereas <italic>Hdac2</italic> ΚO mice appeared indistinguishable from their littermates, <italic>Hdac3</italic> ΚO mice were significantly smaller in size and had lower body weight, with more than half of the total number of <italic>Hdac3</italic> ΚO pups not surviving to five months of age, precluding some aspects of this study; notably, we were unable to generate sufficient numbers of <italic>Hdac3</italic> KO mice to perform RNA-seq. We hypothesize that this may be the result of <italic>Ppp1r1b</italic>-driven Cre expression in cell types outside MSNs during development and/or in the periphery that are sensitive to levels of HDAC3, for example in the gut or liver (<xref ref-type="bibr" rid="bib1">Alenghat et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Knutson et al., 2008</xref>). Nonetheless, this observation highlights the non-redundant functions of HDAC2 and HDAC3 within the mammalian body.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>MSN-specific deletion of <italic>Hdac2</italic> or <italic>Hdac3</italic>.</title><p>(<bold>A</bold>) D9-Cre mice, expressing Cre recombinase from the <italic>Ppp1r1b</italic> promoter from 5 to 6 weeks of age, were crossed with floxed <italic>Hdac2</italic> or <italic>Hdac3</italic> mice (schematic illustrates exons flanked by <italic>loxP</italic> sites), and with <italic>Htt</italic><sup>Q111/+</sup> mice to obtain mice with or without a single <italic>Htt</italic><sup>Q111</sup> allele either expressing HDAC2/3 (WT) or with <italic>Hdac2</italic> or <italic>Hdac3</italic> allele deleted in MSNs (KO). See <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> for a detailed breeding scheme. (<bold>B</bold>) Fluorescent micrographs of 10 week <italic>Htt<sup>Q111/+</sup> Hdac2</italic> KO (left) and <italic>Htt<sup>Q111/+</sup> Hdac3</italic> KO (right) striata co-stained with DARPP-32/HDAC2 and DARPP-32/HDAC3 antibodies, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Detailed mating scheme.</title><p>(<bold>A</bold>) The scheme is shown for <italic>Hdac2</italic> but the same scheme was implemented for <italic>Hdac3.</italic> Mice carrying conditional floxed <italic>Hdac2</italic> or <italic>Hdac3</italic> alleles were crossed with <italic>Htt</italic><sup>Q111</sup> mice (cross 1) and, in a separate cross, with D9-Cre mice (cross 2). Progeny from the two crosses were bred together (cross 3) to obtain <italic>Htt<sup>+/+</sup></italic> and <italic>Htt</italic><sup>Q111/+</sup> mice with or without the <italic>Hdac2</italic> or <italic>Hdac3</italic> floxed allele and/or Cre transgene. Mice harboring either no floxed <italic>Hdac</italic> alleles in the presence of Cre or one, two, or no floxed alleles in the absence of Cre were wild-type with respect to HDAC expression and are referred to as <italic>Hdac2</italic> WT or <italic>Hdac3</italic> WT. Mice homozygous for the floxed <italic>Hdac2 or Hdac3</italic> alleles and expressing Cre are referred to as <italic>Hdac2</italic> ΚO or <italic>Hdac3</italic> ΚO. In these mice, the <italic>Hdac2</italic> or <italic>Hdac3</italic> alleles are deleted in MSNs and they do not express HDAC2 or HDAC3 in MSNs. (<bold>B</bold>). In a separate cross, <italic>Htt</italic><sup>Q111/+</sup> mice were crossed with D9-Cre mice to generate <italic>Htt</italic><sup>+/+</sup> and <italic>Htt</italic><sup>Q111/+</sup> mice with or without the Cre transgene, with the purpose of testing the effect of Cre expression alone.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Upregulation of HDAC1 in <italic>Hdac2</italic> KO striata.</title><p>(<bold>A</bold>) Total lysates of contralateral striata of a subset of 5-month <italic>Hdac2</italic> KO mice from the RNAseq cohort (N = 4 for each of the four compared genotypes, as indicated on the bar graphs), probed with anti-HDAC2 antibody (top) and subsequently with anti-HDAC1 antibody (bottom). HDAC2 and HDAC1 bands are indicated by arrows. (<bold>B</bold>) Quantification of HDAC2 and HDAC1 levels as detected by western blot, normalized by total protein detected by Novex membrane protein stain. ‘Relative units’ represent the density of HDAC2 or HDAC1 band divided by the density of the total protein stain in the corresponding lane, quantified for each mouse and averaged over the number of mice in each genotype group. Error bars show SD.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>HDAC2 and HDAC1 protein levels in Hdac2 KO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-fig1-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title><italic>Hdac2</italic> or <italic>Hdac3</italic> knockout in striatal MSNs does not affect HDAC2 or HDAC3 levels in cortex.</title><p>Shown are fluorescent micrographs of somatosensory cortex of 10-week-old <italic>Hdac2</italic> KO (<bold>A</bold>) and <italic>Hdac3</italic> KO (<bold>B</bold>) mice immunostained with anti-HDAC2 and anti-HDAC3 antibody, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig1-figsupp3-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Impact of MSN-specific <italic>Hdac2</italic> knockout and of the <italic>Htt</italic><sup>Q111</sup> allele on the transcriptome</title><p>Due to the central role of HDAC2 in regulating transcription (<xref ref-type="bibr" rid="bib44">Kelly and Cowley, 2013</xref>) and previous evidence for a beneficial effect of HDAC inhibitors in HD mouse models, we first performed RNA-seq in the <italic>Hdac2</italic> KO cohort to assess both the global impact of MSN-specific <italic>Hdac2</italic> KO and the extent to which genes dysregulated by the expression of the <italic>Htt</italic><sup>Q111</sup> allele might be reversed. Transcriptional dysregulation occurs in <italic>Htt</italic><sup>Q111/+</sup> mice by 2–6 months of age (<xref ref-type="bibr" rid="bib2">Ament et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Bragg et al., 2017</xref>). We performed RNA-seq in striata from 5-month <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT, <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> WT, <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> ΚO and <italic>Htt</italic><sup>Q111/+</sup> <italic>Hdac2</italic> ΚO mice (<xref ref-type="fig" rid="fig2">Figure 2</xref>). <italic>Htt</italic><sup>Q111/+</sup> mice with <italic>Hdac2</italic> WT and <italic>Hdac2</italic> KO genotypes were matched for constitutive CAG repeat lengths (<xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>). Analyses of exon-specific <italic>Hdac2</italic> transcripts revealed marked depletion of reads mapping to exons 2, 3, and 4 as well as the presence of exon 1-exon 5 splice junction reads in the <italic>Hdac2</italic> ΚO mice, consistent with Cre-mediated deletion of exons 2–4 (<xref ref-type="bibr" rid="bib73">Montgomery et al., 2007</xref>), and further supported by detection of Cre-specific transcripts in these mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Analyses of transcript levels of other <italic>Hdac</italic> genes revealed a compensatory increase in <italic>Hdac1</italic> transcripts in <italic>Hdac2</italic> ΚO striata, consistent with western blots from the same mice (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>), but no major impact on the expression level of any other <italic>Hdac</italic> gene (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The <italic>Htt</italic><sup>Q111</sup> allele did not alter expression of <italic>Hdac</italic> genes (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), consistent with previous observations that the <italic>HTT</italic> mutation does not influence HDAC expression in primary neurons, or in CAG140 knock-in mice, although expression of some HDACs was altered in R6/2 exon 1 transgenic mice (<xref ref-type="bibr" rid="bib35">Hoshino et al., 2003</xref>; <xref ref-type="bibr" rid="bib81">Quinti et al., 2010</xref>). Principal component analysis (PCA) of the full dataset revealed that the greatest variance between samples was attributable to <italic>Hdac2</italic> genotype, with the second principal component largely separating males and females. There was no clear distinction between samples based on <italic>Htt</italic> genotype (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Global levels of striatal H3K9 and H4K12 acetylation, previously shown to be sensitive to HDAC2 levels in the brain (<xref ref-type="bibr" rid="bib31">Guan et al., 2009</xref>), revealed overall fairly subtle alterations that appeared to depend on age (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>), consistent with cell-type-specific knockout of <italic>Hdac2</italic> and previous observations that the effects of HDAC inhibition on histone acetylation are restricted to specific genomic loci (<xref ref-type="bibr" rid="bib64">Lopez-Atalaya et al., 2013</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>RNA-seq analyses in <italic>Htt</italic><sup>Q111</sup> striata with MSN-specific <italic>Hdac2</italic> knockout.</title><p>Results of differential gene expression analyses showing the number of differentially expressed genes (DEGs) for each of five contrasts. Number and % of DEGs at nominal p&lt;0.05 or FDR adjusted p&lt;0.05 are indicated. Total number of genes analyzed: contrast 1 = 17,132; contrast 2 = 17,175; contrast 3 = 17,139; contrast 4 = 17,116; contrast 5 = 17,094. The number of male (M) and female (F) mice in each group is indicated.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Expression of <italic>Hdac</italic> genes and Cre recombinase.</title><p>(<bold>A</bold>) <italic>Cre</italic> expression is increased in <italic>Hdac2</italic> KO mice that also express the <italic>DARPP-32-Cre</italic> transgene. (<bold>B</bold>) Expression level of each <italic>Hdac2</italic> exon showing reduced expression of exons 2–4 in <italic>Hdac2</italic> KO mice, as predicted from the floxed <italic>Hdac2</italic> allele with <italic>loxP</italic> sites spanning these exons (<xref ref-type="bibr" rid="bib73">Montgomery et al., 2007</xref>). (<bold>C</bold>) Expression levels of other <italic>Hdac</italic> genes. <italic>Hdac1</italic> expression is upregulated in <italic>Hdac2</italic> KO mice. Note that mouse reference genome we used in this study, GRCm38 v. 75 had two Ensembl gene identifiers for <italic>Hdac4</italic>, ENSMUSG00000073617 (third panel on the first row) and ENSMUSG00000026313 (fourth panel on the first row).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Principal Components Analyses (PCA).</title><p>PC1 separates gene expression by <italic>Hdac2</italic> genotype (<bold>A</bold>), while PC2 separates gene expression largely by sex (<bold>B</bold>). Gene expression data does not clearly separate the samples by <italic>Htt</italic><sup>Q111</sup> genotype (<bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Global H3K9 and H4K12 acetylation levels.</title><p>(<bold>A</bold>) Quantification of acetylated Lys9 on histone H3, normalized by total H3 level, as detected by western blot. ‘Relative units’ represent the density of AcH3K9 band divided by the density of the corresponding histone H3 band, quantified for each mouse and averaged over the number of mice in each genotype group. (<bold>B</bold>) Quantification of acetylated Lys12 on histone H4 as detected by western blot, normalized by total protein detected by Novex membrane protein stain. ‘Relative units’ represent the density of AcH4K12 band divided by the density of the total protein stain in the corresponding lane, quantified for each mouse and averaged over the number of mice in each genotype group. Error bars show standard deviation. *<italic>Hdac2</italic> WT: mean 0.96, 95% CI [0.68,1.24]; <italic>Hdac2</italic> KO: mean 1.78, 95% CI [0.99, 2.56]; 2-tailed unpaired t-test p=0.021 in H4K12 acetylation. Numbers of mice for each group are indicated on the bar graphs.</p><p><supplementary-material id="fig2s3sdata1"><label>Figure 2—figure supplement 3—source data 1.</label><caption><title>AcH3K9 and AcH4K12 levels in Hdac2 KO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-fig2-figsupp3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Cross-study comparison of <italic>Htt</italic><sup>Q111</sup>-differentially expressed genes.</title><p>RNA-seq data from striata of B6J.<italic>Htt</italic><sup>Q111/+</sup> and <italic>Htt</italic><sup>+/+</sup> mice described in <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref> were analyzed in the same way as the current study for comparison. (<bold>A</bold>) The number of dysregulated genes (all, up- or down-regulated) in each study at two different statistical significance thresholds. (<bold>B</bold>) The number of overlapping up- or down-regulated genes between the two studies. Numbers in parentheses show the number of shared genes in each study. (<bold>C</bold>) Heat map of the 29 most significantly up or down-regulated genes shared between the two studies (FDR adjusted p&lt;0.05).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig2-figsupp4-v2.tif"/></fig></fig-group><p>To assess the impact of the two genetic mutations (<italic>Hdac2</italic> KO and <italic>Htt</italic><sup>Q111</sup>) on the transcriptome we performed differential gene expression analyses to test the effects of the MSN-specific <italic>Hdac2</italic> KO in the <italic>Htt<sup>+/+</sup></italic> background (contrast 1), or the <italic>Htt</italic><sup>Q111/+</sup> background (contrast 2), and the effects of the <italic>Htt</italic><sup>Q111</sup> allele in a <italic>Hdac2</italic> WT background (contrast 3) or the <italic>Hdac2</italic> KO background (contrast 4). We also compared <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO and <italic>Htt</italic><sup>+/+ </sup><italic>Hdac2</italic> WT striata (contrast 5) (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="supplementary-material" rid="sdata2">Source data 2</xref>). <xref ref-type="fig" rid="fig2">Figure 2</xref> displays the number of differentially expressed genes (DEGs) in each of the differential gene expression contrasts. Strikingly, knockout of <italic>Hdac2</italic> in MSNs elicited a substantial transcriptional response, roughly comparable in <italic>Htt</italic><sup>+/+</sup> or <italic>Htt</italic><sup>Q111/+</sup> mice, with ~11–12% of genes statistically significantly dysregulated (FDR adjusted p&lt;0.05) and being both up- and down-regulated in approximately equal proportion. In line with previous studies (<xref ref-type="bibr" rid="bib2">Ament et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Bragg et al., 2017</xref>), <italic>Htt</italic><sup>Q111/+</sup> striata exhibited a large number of genes that were both up- and down-regulated, although only a moderate number reached statistical significance when accounting for multiple testing. Interestingly, the transcriptional dysregulation mediated by the <italic>Htt</italic><sup>Q111</sup> allele appeared to be somewhat muted in the <italic>Hdac2</italic> knockout background (<xref ref-type="fig" rid="fig2">Figure 2</xref>- compare contrasts 3 and 4). The comparison of <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO and <italic>Htt</italic><sup>+/+</sup><italic>Hdac2</italic> WT striata indicated an effect similar in magnitude to that of the <italic>Hdac2</italic> KO mutation alone.</p><p>We compared the <italic>Htt</italic><sup>Q111</sup>-DEGs in this study with those in striata of heterozygous <italic>Htt</italic><sup>Q111/+</sup> mice in a previous study by <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref>. In the Langfelder study, heterozygous <italic>Htt</italic><sup>Q111/+</sup> mice were analyzed as part of a larger allelic series of <italic>Htt</italic> CAG knock-in mice; here, we reanalyzed the Langfelder data comparing <italic>Htt</italic><sup>Q111/+</sup> to wild-type striata using the same analysis method used in the current study (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>; Materials and methods). A large proportion of gene expression changes in the current study overlapped with those in the Langfelder dataset, although many more DEGs were identified in the latter (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4A, B</xref>). Differences may be due to the age of the mice - 5 months in current study and 6 months in the Langfelder study – especially considering the dramatic increase in transcriptional dysregulation that occurs between 2 and 6 months of age (<xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref>). In addition, factors such as genetic heterogeneity (Materials and methods) and disproportionate male:female ratios of mice in our study may contribute to reduced power to detect <italic>Htt</italic><sup>Q111</sup>- driven transcriptional changes. Importantly, the vast majority of the common genes were dysregulated in the same direction (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4B</xref>); at a nominal p value of &lt; 0.05, 721 genes were coordinately dysregulated (298 up-regulated in both studies and 433 down-regulated in both studies). Correcting for multiple testing (FDR adjusted p&lt;0.05), 29 genes were coordinately dysregulated (11 up-regulated in both studies and 18 down-regulated in both studies). These 29 genes are displayed in <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4C</xref>, highlighting several genes including <italic>Ppp1r1b, Penk and Pde10a</italic> also found to be dysregulated in <italic>Htt</italic><sup>Q111/+</sup> mice in additional previous studies (<xref ref-type="bibr" rid="bib2">Ament et al., 2017</xref>; <xref ref-type="bibr" rid="bib10">Bragg et al., 2017</xref>). We refer to these 29 genes as ‘commonly dysregulated genes’ in downstream analyses.</p></sec><sec id="s2-3"><title>Overlaps in gene dysregulation elicited by the <italic>Hdac2</italic> KO and the <italic>Htt</italic><sup>Q111</sup> allele</title><p>To gain insight into the transcriptionally dysregulated genes in each of the four contrasts we determined the enrichment of the DEGs in biological pathways (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="supplementary-material" rid="sdata3">Source data 3</xref>). These analyses revealed that the <italic>Hdac2</italic> KO and <italic>Htt</italic><sup>Q111</sup> mutations altered a number of shared processes and pathways. For example, pathways related to cell adhesion, plasma membrane, calcium ion binding and morphine addiction were amongst the most significantly up-regulated in response to either the <italic>Hdac2</italic> KO mutation (<xref ref-type="fig" rid="fig3">Figure 3</xref>, contrast 1) or the <italic>Htt</italic><sup>Q111</sup> allele (<xref ref-type="fig" rid="fig3">Figure 3</xref>, contrast 3). Broadly, pathways related to neuronal function were down-regulated in both in <italic>Hdac2</italic> KO striata and <italic>Htt</italic><sup>Q111/+</sup> striata, although the nature of these pathways was somewhat different, for example an enrichment for signaling pathways in <italic>Htt</italic><sup>Q111/+</sup> striata and for pathways related to neuronal and synapse structure in the <italic>Hdac2</italic> KO. To gain further insight into commonalities between the impacts of <italic>Hdac2</italic> KO and <italic>Htt</italic><sup>Q111</sup> mutations on transcriptional dysregulation we determined the overlaps in the DEGs and in the pathways enriched for DEGs elicited by the two mutations (i.e. overlap between contrasts 1 and 3) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, yellow highlighted cells). There was a highly significant overlap in the DEGs and enriched pathways due to the <italic>Hdac2</italic> KO or the <italic>Htt</italic><sup>Q111</sup> allele, largely reflecting overlaps in DEGs and enriched pathways altered in the same direction, i.e. up- or down-regulated in both conditions (statistical tests of enrichment were performed using one-sided Fisher exact tests – see Materials and methods, and results are shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). We also compared the effect of the <italic>Hdac2</italic> KO in the presence and absence of the <italic>Htt</italic><sup>Q111</sup> allele (<xref ref-type="fig" rid="fig3">Figure 3</xref>, contrasts 1 and 2). There were highly significant overlaps in the DEGs and enriched pathways altered in the same direction between two contrasts (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>; pink highlighted cells). Finally, we compared the effect of <italic>the Htt</italic><sup>Q111</sup> allele in the presence and absence of the <italic>Hdac2</italic> KO mutation (<xref ref-type="fig" rid="fig3">Figure 3</xref>, contrasts 3 and 4). The pathways downregulated by the <italic>Htt</italic><sup>Q111</sup> allele in the <italic>Hdac2</italic> KO mice again largely encompassed those involved in neuronal function, whilst the most significantly upregulated pathways highlighted the extracellular matrix rather than cell adhesion pathways that were predominantly upregulated by the <italic>Htt</italic><sup>Q111</sup> allele on the <italic>Hdac2</italic> WT background. Again, there were significant overlaps in DEGs and enriched pathways that were altered in the same direction by the <italic>Htt</italic><sup>Q111</sup> allele in <italic>Hdac2</italic> WT and KO conditions (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, blue highlighted cells).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Pathway enrichment of differentially expressed genes.</title><p>The most significantly enriched pathways that are up- or down-regulated in each of four differential gene expression contrasts are shown. Numbers at the end of each bar show the number of genes represented in each pathway. For contrasts 1 and 2, DEGs used in the pathway analyses met the FDR &lt; 0.05 threshold; for contrasts 3 and 4 DEG genes had a nominal p&lt;0.05. The full set of pathways analyses is provided in <xref ref-type="supplementary-material" rid="sdata2">Source data 2</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Overlaps of differentially expressed genes and enriched pathways in each of the four contrasts.</title><p>Numbers of DEGs genes (<bold>A</bold>) and enriched pathways (<bold>B</bold>) that overlap between the four contrasts at different significance threshold cut-offs. (<bold>C</bold>) The significance, determined using a one-tailed Fisher Exact test, of the enrichment of overlapping genes/pathways, for differentially expressed genes (p&lt;0.05), or pathway enrichment (p&lt;0.05 based on DEGs at p&lt;0.05). The colors highlight overlaps between specific contrasts referred to in the text.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig3-figsupp1-v2.tif"/></fig></fig-group><p>It should be noted that a direct comparison of gene dysregulation elicited by the <italic>Htt</italic><sup>Q111</sup> allele and <italic>Hdac2</italic> KO is complicated by the fact that the <italic>Htt</italic><sup>Q111</sup> allele is constitutively expressed whereas the <italic>Hdac2</italic> KO mutation is specific to striatal MSNs. Nevertheless, taken together, the results of our differential gene expression analyses, pathway enrichment and overlap analyses indicate that: (1) Genes and pathways can be dysregulated in the same direction by either the <italic>Htt</italic><sup>Q111</sup> allele or the <italic>Hdac2</italic> KO mutation; (2) There is substantial overlap in gene dysregulation by the <italic>Hdac2</italic> KO mutation in the presence or absence of the <italic>Htt</italic><sup>Q111</sup> allele, and vice versa. (3) The impact of one mutation depends in part on the presence of the other.</p></sec><sec id="s2-4"><title>A subset of genes dysregulated in <italic>Htt</italic><sup>Q111/+</sup> striata is reversed by knockout of <italic>Hdac2</italic> in MSNs</title><p>We were interested to determine the extent to which <italic>Htt</italic><sup>Q111</sup>-dysregulated genes might be reversed by the MSN-specific <italic>Hdac2</italic> KO. However, given the overlap in gene dysregulation elicited by either the <italic>Htt</italic><sup>Q111</sup> allele or the <italic>Hdac2</italic> KO (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) we wondered whether <italic>Htt</italic><sup>Q111</sup>-dysregulated genes might in fact be further changed in the same direction by the <italic>Hdac2</italic> KO. To assess this, we first determined the set of genes that was dysregulated both in the comparison of <italic>Htt</italic><sup>Q111/+</sup> vs. <italic>Htt</italic><sup>+/+</sup> striata in the <italic>Hdac2</italic> WT background (contrast 3) and in the comparison of <italic>Hdac2</italic> KO vs. <italic>Hdac2</italic> WT striata in the <italic>Htt</italic><sup>Q111/+</sup> background (contrast 2) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, left table; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, green highlighted cells, <xref ref-type="supplementary-material" rid="sdata4">Source data 4</xref>). We identified 520 DEGs common to both comparisons applying a nominal p value &lt; 0.05 to each differential gene expression analysis, while 17 were common to both comparisons applying an FDR-adjusted p value&lt;0.05. The overlapping genes included both those that changed in opposite directions, i.e. up-regulated by <italic>Htt</italic><sup>Q111</sup> and then down-regulated by <italic>Hdac2</italic> KO and vice versa, and those that changed in the same direction. The former (69 up-regulated by <italic>Htt</italic><sup>Q111</sup> and down-regulated by <italic>Hdac2</italic> KO plus 144 down-regulated by <italic>Htt</italic><sup>Q111</sup> and up-regulated by <italic>Hdac2</italic> KO) comprise 17% of all <italic>Htt</italic><sup>Q111</sup>-dysregulated genes (p&lt;0.05), indicating possible rescue. The latter (158 up-regulated and 149 down-regulated by <italic>Htt</italic><sup>Q111</sup> and by <italic>Hdac2</italic> KO in <italic>Htt</italic><sup>Q111</sup> striata) comprise ~24% of all <italic>Htt</italic><sup>Q111</sup>-dysregulated genes (p&lt;0.05), indicating a sizeable proportion of genes for which the <italic>Htt</italic><sup>Q111</sup>-mediated dysregulation is exacerbated by the <italic>Hdac2</italic> KO. Therefore, it appears that gene dysregulation elicited by the <italic>Htt<sup>Q</sup></italic><sup>111</sup> allele can be both exacerbated and reversed by <italic>Hdac2</italic> KO.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Rescue by <italic>Hdac2</italic> KO of gene expression levels of a subset of genes dysregulated by the <italic>Htt</italic><sup>Q111</sup> allele.</title><p>(<bold>A</bold>) To identify genes dysregulated by the <italic>Htt</italic><sup>Q111</sup> allele and by <italic>Hdac2</italic> KO in <italic>Htt</italic><sup>Q111/+</sup> mice, the overlapping genes in contrasts 3 and 2 were identified (left table). This shows the numbers of genes (p&lt;0.05) up-regulated by <italic>Htt</italic><sup>Q111</sup> and either further up-regulated, or down-regulated by <italic>Hdac2</italic> KO in <italic>Htt</italic><sup>Q111/+</sup> mice, and the numbers of genes down-regulated by <italic>Htt</italic><sup>Q111</sup> and either further down-regulated, or up-regulated by <italic>Hdac2</italic> KO in <italic>Htt</italic><sup>Q111/+</sup> mice. To identify <italic>Htt</italic><sup>Q111</sup>-dysregulated genes whose expression level was normalized by <italic>Hdac2</italic> KO, genes from the contrast 3/2 overlap whose expression level did not differ significantly (p&gt;0.05) between <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT and <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO striata were identified (right table). (<bold>B</bold>) Heat map of the 97 genes down-regulated by <italic>Htt</italic><sup>Q111</sup> and up-regulated by <italic>Hdac2</italic> KO in <italic>Htt</italic><sup>Q111/+</sup> striata and of the 55 genes up-regulated by <italic>Htt</italic><sup>Q111</sup> and down-regulated by <italic>Hdac2</italic> KO in <italic>Htt</italic><sup>Q111/+</sup> striata, whose expression levels did not differ significantly between <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT and <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO. (<bold>C</bold>) Examples of four such genes, two down-regulated by <italic>Htt</italic><sup>Q111</sup> and two up-regulated by <italic>Htt</italic><sup>Q111</sup> are displayed as box-plots.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Impact of <italic>Hdac2</italic> KO on the most significantly dysregulated genes common to this study and Langfelder et al.</title><p>Box-plots showing expression levels of the 29 genes significantly dysregulated in <italic>Htt</italic><sup>Q111/+</sup> striata (FDR-adjusted p&lt;0.05) in both the current study and in <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref> across all four genotypes. (<bold>A</bold>) Two genes had expression levels that did not differ significantly between <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT and <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO striata; thus the down-regulation of these genes is considered to be rescued by <italic>Hdac2</italic> KO. (<bold>B</bold>) 13 genes had expression levels that were changed by <italic>Hdac2</italic> KO in <italic>Htt<sup>Q</sup></italic><sup>111</sup> mice; for most of these, <italic>Hdac2</italic> KO further dysregulated gene expression in the same direction as the <italic>Htt</italic><sup>Q111/+</sup> allele. (<bold>C</bold>) For 14 genes there was no change in gene expression in <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO compared to <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> WT striata.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig4-figsupp1-v2.tif"/></fig></fig-group><p>To investigate reversal of <italic>Htt</italic><sup>Q111</sup>-mediated dysregulation by <italic>Hdac2</italic> KO we performed t-tests on the 520 overlapping genes to define genes whose expression level did not differ significantly (p&gt;0.05) between <italic>Htt</italic><sup>+/+ </sup><italic>Hdac2</italic> WT and <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO striata. i.e. reversion of gene expression to wild-type in the presence of both mutant alleles (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, right table). 152 genes had expression levels that did not differ significantly between these two genotypes, of which 97 were down-regulated by <italic>Htt</italic><sup>Q111</sup> and up-regulated by <italic>Hdac2</italic> KO and 55 were up-regulated by <italic>Htt</italic><sup>Q111</sup> and down-regulated by <italic>Hdac2</italic> KO (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, lower table, <xref ref-type="supplementary-material" rid="sdata4">Source data 4</xref>). These genes represent ~12% of the total number of <italic>Htt</italic><sup>Q111</sup>-dysregulated genes (p&lt;0.05). Note that a far greater number of genes did show significant differences in expression between <italic>Htt</italic><sup>+/+ </sup><italic>Hdac2</italic> WT and <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO striata (<xref ref-type="fig" rid="fig2">Figure 2</xref>, contrast 5). Gene expression values for these 152 genes across all four genotypes are displayed as a heat map in <xref ref-type="fig" rid="fig4">Figure 4B</xref>, highlighting the comparable gene expression levels in <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT and <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO striata (middle two panels) for both <italic>Htt</italic><sup>Q111/+</sup> down-regulated genes (left hand heat map) and <italic>Htt</italic><sup>Q111/+</sup> up-regulated genes (right hand heat map). Also apparent are effects of the <italic>Hdac2</italic> KO on these genes in <italic>Htt</italic><sup>+/+</sup> striata (compare second and fourth panels), though to a lesser degree than in <italic>Htt</italic><sup>Q111/+</sup> striata. Examples of two of these <italic>Htt</italic><sup>Q111</sup> down-regulated genes and two <italic>Htt</italic><sup>Q111</sup>-up-regulted genes are displayed as box-plots in <xref ref-type="fig" rid="fig4">Figure 4C</xref>. Of interest, one of these genes is <italic>Tcerg</italic>, a candidate human onset modifier (<xref ref-type="bibr" rid="bib25">Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium, 2019</xref>).</p><p>We further specifically examined the impact of <italic>Hdac2</italic> KO on the 29 genes (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>) commonly dysregulated (FDR adjusted p&lt;0.05) in the current study and in the Langfelder study (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>) Two of these 29 genes (<italic>Ppp1r1b</italic> and <italic>Slc29a1</italic>) overlapped with the set of 152 genes whose expression level did not differ between <italic>Htt</italic><sup>+/+</sup><italic> Hdac2</italic> WT and <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO (<xref ref-type="fig" rid="fig4">Figure 4D</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). An additional 13 (<italic>Cd200, Dmkn, Dsg, Gpd1, Inpp5j, Myo5c, Pdp1, Ppp4r4, Ptprh, Ptprv, Sbsn, Syp, and Vill)</italic> overlapped with the set of 520 genes whose expression level was altered by <italic>Htt</italic><sup>Q111</sup> and by <italic>Hdac2</italic> KO in <italic>Htt</italic><sup>Q111</sup> mice, but for which the <italic>Htt</italic><sup>Q111</sup>-mediated gene dysregulation was not normalized by <italic>Hdac2</italic> KO in <italic>Htt</italic><sup>Q111</sup> mice. For the majority of these genes, <italic>Hdac2</italic> KO altered gene expression in the same direction as the <italic>Htt</italic><sup>Q111</sup> allele, indicating an exacerbation of the <italic>Htt</italic><sup>Q111</sup>-mediated dysregulation (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). For 14 of the 29 commonly <italic>Htt</italic><sup>Q111</sup>-dysregulated genes (<italic>B3gnt2, C4a, Foxp4, Gpr6, Homer1, Lrrtm4, Myadm, Ndst3, Olfm3, Pde10a, Penk, Rgs9, Trpv2, Vrk1</italic>), their expression level was not further altered by the <italic>Hdac2</italic> KO (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>).</p><p>Interestingly, we noticed that in these 29 commonly dysregulated genes, the <italic>relative</italic> impact of the <italic>Htt</italic><sup>Q111</sup> allele was reduced in <italic>Hdac2</italic> KO mice. i.e. the difference in gene expression between <italic>Htt</italic><sup>Q111/+</sup> and <italic>Htt</italic><sup>+/+</sup> is less in <italic>Hdac2</italic> KO than in <italic>Hdac2</italic> WT striata (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). To better visualize this, we plotted the absolute log 2-fold change (i.e. log2 fold-change regardless of the direction of change) between <italic>Htt</italic><sup>Q111/+</sup> and <italic>Htt</italic><sup>+/+</sup> for each of these genes in <italic>Hdac2</italic> WT mice and in <italic>Hdac2</italic> KO mice (<xref ref-type="fig" rid="fig5">Figure 5</xref>), highlighting the reduced fold-change for each of these genes in the <italic>Hdac</italic>2 KO, though to different degrees. Permutation (Materials and methods) showed a statistically significant enrichment for a reduced relative impact (absolute log2 fold-change) of the <italic>Htt</italic><sup>Q111</sup> allele in the <italic>Hdac2</italic> KO in these 29 genes (p&lt;1e-5).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>Hdac2</italic> KO reduces the relative impact of the <italic>Htt</italic><sup>Q111</sup> allele.</title><p>Absolute log2 fold-change of gene expression differences between <italic>Htt</italic><sup>Q111/+</sup> and <italic>Htt</italic><sup>+/+</sup> were determined in <italic>Hdac2</italic> WT mice and in <italic>Hdac2</italic> KO mice as a measure of gene expression change regardless of direction of effect. x-axis indicates the set of 29 genes significantly dysregulated by <italic>Htt</italic><sup>Q111</sup> (FDR adjusted p&lt;0.05) in both this study and in <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref>; <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig5-v2.tif"/></fig><p>We therefore observe the following: (1) The absolute expression levels of a subset of <italic>Htt</italic><sup>Q111</sup>-dysregulated genes are effectively normalized in <italic>Htt</italic><sup>Q111</sup> mice harboring the <italic>Hdac2</italic> KO mutation to levels present in wild-type mice, suggesting rescue of these gene expression changes; (2) The normalization of absolute expression levels of a subset of <italic>Htt</italic><sup>Q111</sup>-dysregulated genes occurs in a substantially larger background of gene dysregulation elicited by the <italic>Hdac2</italic> KO; (3) In addition, and apparent in a set of the most significantly <italic>Htt</italic><sup>Q111</sup>-dysregulated genes, <italic>Hdac2</italic> KO lessens the <italic>relative</italic> impact of the <italic>Htt</italic><sup>Q111</sup> mutation, regardless of the absolute effect of the <italic>Hdac2</italic> KO on the level of gene expression. Taken together, our results indicate a potentially complex relationship between <italic>Hdac2</italic> KO and the <italic>Htt</italic><sup>Q111</sup> mutation.</p></sec><sec id="s2-5"><title><italic>Hdac2</italic> and <italic>Hdac3</italic> modify CAG expansion in <italic>Htt</italic><sup>Q111</sup> knock-in mice</title><p>We next tested the impact of MSN-specific <italic>Hdac2</italic> or <italic>Hdac3</italic> KO on CAG expansion to determine whether these genes might be involved in the mechanism that drives the rate of phenotypic onset in this vulnerable cell population. We analyzed and quantified CAG striatal expansions in ABI GeneMapper traces of <italic>HTT</italic> CAG repeat-containing PCR products from cohorts of <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> ΚO mice at 2.5, 5, and 10 months of age and from <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac3</italic> KO mice at 5 months of age (<xref ref-type="fig" rid="fig6">Figure 6</xref>). This analysis provides a measure of repeat length distribution across the entire population of striatal cells, and as MSNs contribute to the majority of the unstable alleles at the ages analyzed, it is sensitive to changes in repeat length that are confined to MSNs as shown previously (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>). Shown are representative raw GeneMapper traces (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) and normalized GeneMapper data, averaged per genotype, showing the height of each peak and the change in CAG length relative to those of the main (modal) allele (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). We determined an expansion index (<xref ref-type="bibr" rid="bib53">Lee et al., 2010</xref>) from the GeneMapper data, a measure incorporating both the relative height and distance from the main allele of the expansion peaks representing the mean repeat expansion in the cell population (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Mean CAG lengths were matched between genotypes for each cohort (<xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>). At 2.5 months of age, we observed a subtle decrease in expansion index in <italic>Hdac2</italic> ΚO striata that was not statistically significant (<italic>Hdac2</italic> WT: mean 5.76, 95% CI [4.64, 6.88]; <italic>Hdac2</italic> KO: mean 5.29, 95% CI [4.23,6.35]; two-tailed unpaired t-test p=0.42). At 5 months of age the expansion index was significantly reduced in <italic>Hdac2</italic> ΚO striata (<italic>Hdac2</italic> WT: mean 15.22, 95% CI [14.16, 16.28]; <italic>Hdac2</italic> ΚO: mean 12.69, 95% CI [10.91, 14.47]; 2-tailed unpaired t-test p=0.0094), while at 10 months of age, we again observed a small reduction in expansion in <italic>Hdac2</italic> ΚO striata; this was most apparent from the GeneMapper traces of closely CAG repeat-matched mice (panel A), though this did not reach statistical significance (<italic>Hdac2</italic> WT: mean 21.55, 95% CI [19.62–23.48]; <italic>Hdac2</italic> ΚO: mean 20.02, 95% CI [17.1–22.94]; two-tailed unpaired t-test p=0.26) across this cohort of mice with a wide range of CAG lengths (<xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>). Knockout of <italic>Hdac3</italic> in MSNs also decreased the expansion index in the striata of 5 month mice (<italic>Hdac3</italic> WT: mean 13.94, 95% CI [12.81–15.07]; <italic>Hdac3</italic> ΚO: mean 10.43, 95% CI [7.62–13.24]; two-tailed unpaired t-test p=0.0026).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Deletion of <italic>Hdac2</italic> or <italic>Hdac3</italic> in striatal MSNs decreases striatal <italic>HTT</italic> CAG repeat expansions.</title><p>(<bold>A</bold>) Representative GeneMapper traces of PCR-amplified striatal <italic>HTT</italic> CAG repeats from individual mice matched by main allele repeat length within each age group (<xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>). Main allele is marked with a vertical red line and the number of CAG repeats is indicated below. Peaks to the right of the main allele represent CAG repeat expansions. (<bold>B</bold>) Genotype-averaged GeneMapper-derived data showing peak heights normalized by the main allele peak height and CAG change relative to the main allele. (<bold>C</bold>) Mean striatal expansion indices per genotype. Error bars represent standard deviation. **p&lt;0.01 (two-tailed unpaired t-test). *p&lt;0.05, **p&lt;0.01; ***p&lt;0.005 (2-tailed unpaired t-test). Numbers of mice for each group are indicated on the bar graphs.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Expansion Indices in Hdac2 and Hdac3 KO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Expression of <italic>Cre</italic> transgene does not affect <italic>HTT</italic> CAG repeat instability and nuclear huntingtin accumulation in MSNs.</title><p>CAG instability and nuclear mutant huntingtin were measured in a cohort of 5 month <italic>Htt</italic><sup>Q111/+</sup> mice harboring wild-type <italic>Hdac2</italic> and <italic>Hdac3</italic> alleles, either with or without the <italic>DARPP-32 Cre</italic> transgene (<italic>D9-Cre</italic>). (<bold>A</bold>) Genotype-averaged GeneMapper-derived data showing peak heights normalized by the main allele peak height and CAG change relative to the main allele. (<bold>B</bold>) Mean striatal expansion indices. (<bold>C</bold>) Mean integrated intensity of striatal nuclear mutant huntingtin immunostaining normalized by the total number of H3-positive nuclei. Error bars show SD. Numbers of mice for each group are indicated on the bar graphs.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Expansion Indices and mAb5374 nuclear huntingtin immunostaining intensities in Cre-expressing HttQ111 mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-fig6-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Effect of <italic>Hdac2</italic> or <italic>Hdac3</italic> deletion in striatal MSNs on number of DARPP-32-positive cells and DARPP-32 levels.</title><p>DARPP-32 levels (mean integrated intensity; right panels) are quantified as integrated intensity of DARPP-32 immunostaining, normalized by the number of DARPP-32-positive cells (left panels). Refer to <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref> for the cohorts of mice used. (<bold>A</bold>) 2.5 month <italic>Hdac2</italic> KO mice (‘immunohistochemistry (IHC) cohort’). There were no <italic>Htt<sup>+/+</sup></italic> mice in this group. (<bold>B</bold>) Five-month <italic>Hdac2</italic> KO mice (‘instability/IHC cohort’). (<bold>C</bold>) 5 month <italic>Hdac3</italic> KO mice (‘IHC cohort’). (<bold>D</bold>) Five-month <italic>DARPP-32 Cre</italic> (<italic>D9-Cre</italic>) expression control mice. Error bars show SD. Numbers of mice for each group are indicated on the bar graphs. *p&lt;0.05, **p&lt;0.01 (2-tailed unpaired t-tests).</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>DARPP32-positive cells and DARP32 levels in Hdac2 and Hdac3 KO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-fig6-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig6-figsupp2-v2.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>DNA repair gene expression.</title><p>(<bold>A</bold>) Differential expression analysis of DNA repair genes from RNA-seq data in 5-month mice. (<bold>B</bold>) Effect of <italic>Hdac2</italic> KO on levels of <italic>Msh3</italic> mRNA from RNA-seq data in 5-month mice. (<bold>C</bold>) Total lysates of contralateral striata of a subset of mice from the RNA-seq cohort (N = 4 for each of the four genotypes), probed with anti-MSH3 antibody. <italic>Msh3</italic> KO lane is striatal lysate from an <italic>Msh3<sup>-/-</sup></italic> knockout mouse, loaded as negative control. (<bold>D</bold>) Quantification of MSH3 protein levels as detected by western blot, normalized by total protein detected by Novex membrane protein stain. ‘Relative units’ represent the density of MSH3 band divided by the density of the total protein stain in the same lane, quantified for each mouse and averaged over the number of mice in each genotype group. Error bars show S.D. Numbers of mice for each group in the western blot are indicated on the bar graph.</p><p><supplementary-material id="fig6s3sdata1"><label>Figure 6—figure supplement 3—source data 1.</label><caption><title>MSH3 protein levels in Hdac2 KO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-fig6-figsupp3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig6-figsupp3-v2.tif"/></fig></fig-group><p>Note that the expression of Cre recombinase itself did not impact CAG expansion (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>); therefore, the observed impacts on striatal instability are attributable to the <italic>Hdac2</italic> or <italic>Hdac3</italic> genotype of the mice. Further, as neither <italic>Hdac2</italic> ΚO nor <italic>Hdac3</italic> ΚO resulted in any significant loss of MSNs as determined by the number of DARPP-32-positive cells (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>), reduced striatal expansions cannot be readily explained by an altered cellular population biased toward stable alleles. Of note, HDAC3 is required for the long-term maintenance of cerebellar purkinje cells (<xref ref-type="bibr" rid="bib93">Venkatraman et al., 2014</xref>), although its knock-out in the CA1 region of the hippocampus did not have a detrimental effect on cell survival (<xref ref-type="bibr" rid="bib67">McQuown et al., 2011</xref>) in line with the lack of obvious MSN degeneration in our <italic>Hdac3</italic> knockout mice. Thus, HDAC3’s role in neuronal survival may depend on cell-type and/or stage of neuronal development or differentiation.</p><p>Overall, our results support the conclusion that <italic>Hdac2</italic> and <italic>Hdac3</italic> are moderate enhancers of CAG expansion in MSNs of <italic>Htt</italic><sup>Q111/+</sup> mice, with the impact of <italic>Hdac2</italic> KO appearing to depend on the age of the mice. To explore a possible mechanism for instability modification, we investigated the RNA-seq data for expression levels of DNA repair genes that modify repeat instability in mice (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>; <xref ref-type="bibr" rid="bib22">Dragileva et al., 2009</xref>; <xref ref-type="bibr" rid="bib80">Pinto et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Kovtun et al., 2007</xref>; <xref ref-type="bibr" rid="bib72">Mollersen et al., 2012</xref>; <xref ref-type="bibr" rid="bib106">Zhao and Usdin, 2018</xref>; <xref ref-type="bibr" rid="bib71">Miller et al., 2020</xref>). Of these, only <italic>Msh3</italic> mRNA levels were modestly decreased in <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> ΚO striata relative to <italic>Htt<sup>Q111</sup></italic><sup>/+ </sup><italic>Hdac2</italic> KO striata (nominal p&lt;0.01; adjusted p=0.07) (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3A, B</xref>). However, MSH3 protein levels were not reduced in <italic>Hdac2</italic> ΚO striata from these mice (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3C, D</xref>). Therefore, dysregulation of DNA repair gene expression does not provide an obvious explanation for the impact of <italic>Hdac2</italic> KO on CAG expansion.</p></sec><sec id="s2-6"><title>Pharmacological HDAC inhibition promotes CAG contraction in a cell-based assay</title><p>Previous studies have found that Class I HDAC inhibitors suppress CAG expansion (<xref ref-type="bibr" rid="bib42">Jung and Bonini, 2007</xref>; <xref ref-type="bibr" rid="bib87">Suelves et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Debacker et al., 2012</xref>). To test further the impact of HDAC inhibition on CAG instability, we took advantage of a well-established, sensitive human cell-based assay for repeat contractions (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). In this system, a CAG95 repeat is inserted in an intron of an <italic>HPRT</italic> mini-gene construct. Contractions below a threshold of ~38–41 CAGs restore HPRT activity allowing cell growth in selective media. Although the system is blind to expansions, there is relatively good consistency between genetic modifiers identified in this assay and those that modify CAG expansion in mouse models, although the direction of effect can be different (<xref ref-type="bibr" rid="bib61">Lin and Wilson, 2009</xref>). In further support of a role for HDACs as modifiers of CAG instability we found that the small molecule HDAC inhibitors (<xref ref-type="bibr" rid="bib9">Bradner et al., 2010</xref>), SAHA (suberanilohydroxamic acid), and MS-275, both of which share in common the potential inhibition of Zn<sup>2+</sup>-dependent Class I HDACs, and splitomicin, a weak inhibitor of NAD<sup>+</sup> dependent Class III HDACs (Sirtuins) (<xref ref-type="bibr" rid="bib13">Carafa et al., 2011</xref>), stimulated CAG contractions (<xref ref-type="fig" rid="fig7">Figure 7B,C</xref>). Remarkably, we note that the magnitude of effect of the HDAC inhibitors in this contraction assay was comparable to or exceeded that of the various other genetic and pharmacological manipulations we have previously performed (<xref ref-type="bibr" rid="bib61">Lin and Wilson, 2009</xref>; <xref ref-type="bibr" rid="bib60">Lin and Wilson, 2007</xref>; <xref ref-type="bibr" rid="bib62">Lin and Wilson, 2012</xref>; <xref ref-type="bibr" rid="bib37">Hubert et al., 2011</xref>). Note that the enhancement of contractions by HDAC inhibitors in this system is in contrast to the suppressive effect on CAG expansion of genetic or pharmacological inhibition of HDACs in the current study and in previous studies (<xref ref-type="bibr" rid="bib42">Jung and Bonini, 2007</xref>; <xref ref-type="bibr" rid="bib87">Suelves et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Debacker et al., 2012</xref>), although we cannot exclude the possibility that <italic>Hdac2</italic> or <italic>Hdac3</italic> KO in MSNs also stimulated rare contraction events that are not detectable in the GeneMapper assay. Taken together, the data in mice and in cell models, both in this study and previous studies, suggest that Class I HDACs such as HDAC2 and HDAC3, as well as potentially other HDACs, can influence different aspects of CAG instability, perhaps depending on the cell-type and whether the cell is actively dividing or post-mitotic.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>HDAC inhibitors increase instability in selectable cell-based assays for CAG repeat contraction.</title><p>(<bold>A</bold>) <italic>HPRT</italic> mini-gene reporter construct for contraction assay. (<bold>B</bold>) Fold-change in the number of HAT-resistant FLAH25 cells (HPRT+) when treated with HDAC inhibitors relative inhibitors relative to the number of resistant colonies in DMSO-treated cells. Bars show mean +/- SD of bars fold-change relative to DMSO in four biological replicates (independent wells treated with drug). (<bold>C</bold>) CAG repeat lengths in HPRT+ colonies following HDAC inhibitor treatment. DNA was extracted from HPRT+ colonies, and the repeat tract PCR-amplified and sequenced to determine repeat length.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig7-v2.tif"/></fig></sec><sec id="s2-7"><title>Impact of MSN-specific <italic>Hdac2</italic> and <italic>Hdac3</italic> knockout on nuclear huntingtin pathology</title><p><italic>Htt</italic><sup>Q111</sup> mice exhibit both early (~2.5 months) diffusely immunostaining nuclear mutant huntingtin, detected with the anti-huntingtin antibody EM48 (or mAb5374), followed at ~6–12 months by the appearance of discreet intra-nuclear inclusions (<xref ref-type="bibr" rid="bib97">Wheeler et al., 2000</xref>; <xref ref-type="bibr" rid="bib98">Wheeler et al., 2002</xref>; <xref ref-type="bibr" rid="bib63">Lloret et al., 2006</xref>). These cellular phenotypes, which occur selectively in MSNs in <italic>Htt</italic><sup>Q111</sup> mice, are highly CAG repeat length-dependent and are modified by genes that alter somatic expansion (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>; <xref ref-type="bibr" rid="bib80">Pinto et al., 2013</xref>). To assess the impact of MSN-specific <italic>Hdac2</italic> and <italic>Hdac3</italic> KO on these phenotypes we immunostained striatal sections from cohorts of mice (<italic>Hdac2</italic> ΚO at 2.5, 5 and 10 months of age; <italic>Hdac3</italic> KO at 5 months of age) matched for constitutive CAG repeat length (<xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>) with mAb5374 (<xref ref-type="fig" rid="fig8">Figure 8</xref>). With the exception of the 2.5-month <italic>Hdac2</italic> ΚO cohort, mAb5374 immunostaining was performed on the contralateral striata of the same mice analyzed for somatic CAG expansion above.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Impact of MSN-specific <italic>Hdac2</italic> or <italic>Hdac3</italic> knockout on striatal nuclear mutant huntingtin immunostaining phenotypes.</title><p>(<bold>A</bold>) Fluorescent micrographs of <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO striata immunostained with anti-huntingtin mAb5374 and histone H3 antibodies. Mice were matched by CAG repeat length within each age group. Images of 2.5-month and 5-month striata were taken at 40x; images of 10-month striata taken at 20x with 2x digital zoom. The inserts in the 5-month and 10-month <italic>Hdac2</italic> WT mAb5374 images and merged images below highlight the overlap of nuclear huntingtin immunostaining over the entire H3-positive nucleus in the 5-month mice, in contrast to the discrete nuclear huntingtin inclusion immunostaining intensity within the nucleus at 10 months. (<bold>B</bold>) Mean integrated intensity of mAb5374 staining (integrated intensity normalized by the total number of nuclei as determined by the number of H3-positive nuclei) is shown for 2.5-month and 5-month cohorts of <italic>Htt<sup>Q111/+</sup> Hdac2</italic> KO mice. For 10-month mice, the number of nuclei containing an inclusion (we have not observed more than one inclusion per nucleus) was counted as a percentage of the total number of nuclei, determined by histone H3 immunostaining. The 10-month group of mice was divided into two subgroups based on CAG repeat length: low CAG repeat subgroup represented by the first two columns in the graph (<italic>Hdac2</italic> WT CAG 117, 119, 120; <italic>Hdac2</italic> KO CAG 110, 116) and high CAG repeat subgroup represented by the last two columns in the graph (<italic>Hdac2</italic> WT CAG 138, 141, 146; <italic>Hdac2</italic> KO CAG 132, 140, 140). (<bold>C</bold>) Fluorescent micrographs (20x) of 5 month <italic>Hdac3</italic> KO from CAG length-matched mice stained with mAb5374 and histone H3 antibodies (left) and quantified mean integrated intensity of mAb5374 staining (right). 5-months. Numbers of mice for each group are indicated on the bar graphs.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>mAb5474 nulcear intensity and number of nuclear inclusions in Hdac2 and Hdaac3 KO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-fig8-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Huntingtin expression.</title><p>(<bold>A</bold>) Effect of <italic>Hdac2</italic> KO on levels of total huntingtin mRNA (<bold>A</bold>) and on aberrant huntingtin transcripts spanning exon 1 + intron 1 (<bold>B</bold>) from RNA-seq data in 5-month mice. In panel <bold>B</bold>, reads were aligned to knock-in allele sequence comprising human exon one and part of human intron 1 (93). (<bold>C–F</bold>) Huntingtin western blot analyses showing quantification of wild type (<bold>C</bold>) and mutant (<bold>D</bold>) huntingtin as detected by western blot using mAb2166 (<bold>F</bold>). Huntingtin protein bands were normalized by total protein detected by Novex membrane protein stain. (<bold>E</bold>) Average total protein levels as detected by Novex membrane protein stain. ‘Relative units’ represent the density of wild type or mutant huntingtin band divided by the density of the total protein stain in the same lane, quantified for each mouse and averaged over the number of mice in each genotype group (N = 4 for each genotype, as indicated in the bar graphs). Error bars show S.D.</p><p><supplementary-material id="fig8s1sdata1"><label>Figure 8—figure supplement 1—source data 1.</label><caption><title>Zip file: RNAseq_codes_and_files.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-fig8-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55911-fig8-figsupp1-v2.tif"/></fig></fig-group><p>In 2.5- and 5-month mice, we quantified the intensity of the diffuse nuclear signal. <italic>Hdac2</italic> ΚO in MSNs reduced the intensity of diffusely immunostaining nuclear mutant huntingtin at both 2.5 months (<italic>Hdac2</italic> WT: mean 153.9, 95% CI [127.9, 179.9]; <italic>Hdac2</italic> ΚO: mean 96.35, 95% CI [5.63, 187.1]; two-tailed unpaired t-test p=0.025) and 5 months of age (<italic>Hdac2</italic> WT: mean 226.8, 95% CI [159.9, 293.8]; <italic>Hdac2</italic> ΚO: mean 120.9, 95% CI [77.34, 164.5]; two-tailed unpaired t-test p=0.0062), with a stronger impact at 5 months (<xref ref-type="fig" rid="fig8">Figure 8A, B</xref>). Diffuse nuclear huntingtin immunostaining was not altered by Cre expression alone (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). In 10-month mice, nuclei contained distinct inclusions. As the immunoflourescent signal is saturated in these dense inclusions we quantified their number rather than their intensity. This phenotype was variable between mice of the same genotype, largely due to constitutive CAG length. We therefore separated the mice into ‘high’ and ‘low’ CAG groups that reflected different breeding cohorts for comparison between <italic>Hdac2</italic> genotypes (<xref ref-type="fig" rid="fig8">Figure 8A, B</xref>). We observed a decrease in the number of nuclei containing inclusions in the low CAG group that did not reach statistical significance (<italic>Hdac2</italic> WT: mean 8.76, 95% CI [−5.29, 22.81]; <italic>Hdac2</italic> ΚO: mean 0.66, 95% CI [−7.74, 9.06]; 2-tailed unpaired t-test p=0.153), and a statistically significant decrease in the number of cells containing inclusions in the high CAG group (<italic>Hdac2</italic> WT: mean 37.8, 95% CI [21.26, 54.31]; <italic>Hdac2</italic> ΚO: mean 23.44, 95% CI [16.58, 30.31]; 2-tailed unpaired t-test p=0.0261). In the 5-month <italic>Hdac3</italic> KO cohort, we observed a non-statistically significant trend towards decreased diffuse nuclear mutant huntingtin in a small number of immunostained 5-month <italic>Hdac3</italic> ΚO striata (<italic>Hdac3</italic> WT: mean 234, 95% CI [91.13, 376.9]; <italic>Hdac3</italic> ΚO: mean 181.2, 95% CI [72.92, 289.5]; two-tailed unpaired t-test p=0.21). (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). To examine the relationship between CAG expansion and nuclear huntingtin pathology, we compared directly expansion indices and mAb5374 intensity in the 5-month <italic>Hdac2</italic> KO cohort for which we had both measures from the same mice with a reasonable number (N = 5) of each genotype. There was a strong correlation (Pearson r = 0.87, p=0.0011) between mAb5374 intensity and expansion index (<xref ref-type="fig" rid="fig8">Figure 8D</xref>), consistent with somatic CAG expansion as a modifier of this cellular phenotype. Overall, the fairly moderate suppression of the mAb5374 nuclear intensity and nuclear inclusion phenotypes appears in line with the subtly reduced somatic expansion elicited by the <italic>Hdac2</italic> or <italic>Hdac3</italic> gene knockouts.</p><p>As altered huntingtin levels could contribute to the reduced nuclear immunostaining phenotypes, we investigated huntingtin mRNA and protein levels in the <italic>Hdac2</italic> KO mice. In the RNA-seq data, <italic>Hdac2</italic> KO decreased total huntingtin mRNA levels in <italic>Htt</italic><sup>+/+</sup> striata by 5.9% (nominal p=0.06; adjusted p=0.25) and in <italic>Htt</italic><sup>Q111/+</sup> striata by 11% (nominal p&lt;0.001; adjusted p&lt;0.05) (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). However, western blot analyses on the contralateral striata from a subset of the mice used for RNA-seq did not provide evidence for an impact of <italic>Hdac2</italic> KO on steady state levels of wild-type or mutant huntingtin protein (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1C, D</xref>). We also investigated the RNA-seq data for reads spanning exon 1 and intron 1, reflecting aberrantly spliced transcripts identified in a number of other HD models and predicted to encode exon1-containig N-terminal fragment of mutant huntingtin (<xref ref-type="bibr" rid="bib84">Sathasivam et al., 2013</xref>). In support of previous data (<xref ref-type="bibr" rid="bib84">Sathasivam et al., 2013</xref>), we identified exon1-intron1-spanning transcripts in <italic>Htt</italic><sup>Q111/+</sup> striata. However, <italic>Hdac2</italic> KO had no impact on the number of these sequence reads (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1B</xref>). It appears therefore that altered levels of mutant huntingtin or exon1 mutant huntingtin expressed from mis-spliced exon1-intron1 transcripts do not readily explain suppression of nuclear huntingtin pathology elicited by <italic>Hdac2</italic> KO. This is consistent with modification of these highly CAG length-dependent cellular phenotypes occurring as a consequence of reduced CAG repeat lengths in striatal MSNs. However, analyses of larger cohorts of mice as well as analyses of rare expansions not captured using GeneMapper would be needed to rigorously discern <italic>Hdac2</italic> and <italic>Hdac3</italic> genotype effects on nuclear huntingtin pathology phenotypes that are dependent on or independent of somatic CAG expansion.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Identification of genetic modifiers of disease phenotypes in HD mouse models provides an important route to dissecting underlying mechanisms of pathogenesis and ultimately for identifying therapeutic targets. Here, we have taken a cell type-specific genetic knockout approach to investigate the roles of <italic>Hdac2</italic> and <italic>Hdac3</italic> genes in as modifiers of molecular or cellular phenotypes elicited in MSNs by an expanded CAG repeat in heterozygous <italic>Htt</italic><sup>Q111</sup> knock-in mice.</p><p>We restricted our analyses to previously described robust molecular and cellular changes in this model, specifically somatic instability, thought to drive the rate of disease onset in patients, transcriptional dysregulation and nuclear huntingtin pathology. We did not quantify neuronal cell loss and altered astrocytic or microglial cell density as these phenotypes are extremely subtle or not observed in this model. Similarly, we have not examined behavioral endpoints that are also subtle, as such studies would need significantly larger numbers of mice to be sufficiently powered.</p><p>Our results show that MSN-specific knockout of <italic>Hdac2</italic> reversed the transcriptional dysregulation of a subset of genes and resulted in a moderate reduction in somatic CAG expansion and nuclear huntingtin pathology. MSN-specific knockout of <italic>Hdac3</italic> resulted in a comparable reduction in somatic CAG expansion to the <italic>Hdac2</italic> knockout. The impact of genetic knock-out or reduction of several <italic>Hdac</italic> genes (<italic>Hdac3</italic>, <italic>Hdac4</italic>, <italic>Hdac6</italic>, <italic>Hdac7</italic>) has previously been investigated in the R6/2 exon 1 mouse model of HD and in <italic>Hdh</italic>Q150 knock-in mice with the goal of understanding which HDAC targets mediated the beneficial effects of broad-acting HDAC inhibitors (<xref ref-type="bibr" rid="bib4">Benn et al., 2009</xref>; <xref ref-type="bibr" rid="bib7">Bobrowska et al., 2011</xref>; <xref ref-type="bibr" rid="bib75">Moumné et al., 2012</xref>; <xref ref-type="bibr" rid="bib69">Mielcarek et al., 2013</xref>). With the exception of <italic>Hdac6</italic>, the impact of the full knock-out could not be studied due to embryonic or early postnatal lethality. Of the genes tested, only <italic>Hdac4</italic> was found to modify mouse phenotypes, uncovering a novel role for this gene in modulating mutant huntingtin aggregation (<xref ref-type="bibr" rid="bib69">Mielcarek et al., 2013</xref>). In R6/2 mice, the lack of any modifying effect of <italic>Hdac3</italic> may be due to the modest reduction in HDAC3 protein level (to 80% of wild-type overall, or to 60% of wild-type in the nucleus) in the <italic>Hdac3</italic><sup>+/-</sup> mice (<xref ref-type="bibr" rid="bib75">Moumné et al., 2012</xref>).</p><p>Strikingly, knockout of <italic>Hdac2</italic> in MSNs caused substantial transcriptional dysregulation, resulting in both up- and down-regulation of a large number of genes. These findings are consistent with data showing that HDAC1/2 can both positively and negatively regulate gene expression (<xref ref-type="bibr" rid="bib43">Kelly et al., 2018</xref>). It is notable that the majority of mouse tissue-specific deletions of either <italic>Hdac2</italic> or <italic>Hdac1</italic> exhibited no discernible phenotype, presumably due to functional redundancy of the two highly related HDAC1 and HDAC2 proteins (<xref ref-type="bibr" rid="bib43">Kelly et al., 2018</xref>). Our data reveal that, despite its up-regulation, HDAC1 is unable to compensate for the lack of HDAC2 in MSNs, providing evidence for a specific role of HDAC2 in MSNs and supporting distinct functions of HDAC1 and HDAC2 in adult neurons (<xref ref-type="bibr" rid="bib31">Guan et al., 2009</xref>; <xref ref-type="bibr" rid="bib47">Kim et al., 2008</xref>). The expression level of approximately 12% of genes dysregulated by the <italic>Htt</italic><sup>Q111</sup> allele was normalized by the <italic>Hdac2</italic> KO to levels present in wild-type mice. However, this occurs against a much larger background of transcriptional dysregulation elicited by the <italic>Hdac2</italic> KO, with evidence for shared pathways and processes being impacted by both the <italic>Htt</italic><sup>Q111</sup> and <italic>Hdac2</italic> knockout mutations. Indeed, a large proportion (~24%) of genes dysregulated by the <italic>Htt</italic><sup>Q111</sup> allele was further dysregulated in the same direction by the <italic>Hdac2</italic> KO. It should be noted in interpreting these data that the majority of genes dysregulated by the <italic>Htt</italic><sup>Q111</sup> allele did not meet a p value threshold corrected for multiple testing, although a large proportion of genes dysregulated by the <italic>Hdac2</italic> KO did. We therefore examined a core set of 29 genes significantly dysregulated (FDR adjusted p&lt;0.05) by <italic>Htt</italic><sup>Q111</sup> in both in the current study and in Langfelder et al., an extensive investigation of transcriptional dysregulation in HD knock-in mice <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref>. Of these genes, only two met our criteria for rescue (<italic>Ppp1r1b</italic> and <italic>Slc29a1</italic>); for the other genes in this set, <italic>Hdac2</italic> KO either further altered the absolute gene expression level in the same direction as the <italic>Htt</italic><sup>Q111</sup> allele or had no impact on expression. However, in these significantly dysregulated genes, we found that <italic>Hdac2</italic> KO lessened the relative impact of the <italic>Htt<sup>Q</sup></italic><sup>111</sup> allele, regardless of the absolute gene expression change elicited by the <italic>Hdac2</italic> KO. This genetic interaction indicates a functional relationship between these two mutations that may in part reflect a role of huntingtin in regulating the REST-containing transcriptional repressor complex that includes HDAC2 (<xref ref-type="bibr" rid="bib12">Buckley et al., 2010</xref>).</p><p>Several studies have shown beneficial effects of HDAC inhibitors in HD mouse models, including broad-acting HDAC inhibitors SAHA, phenylbutyrate and parabinostat (LBH589), as well as compounds RGFP966 and 4b that show moderate selectivity towards HDAC3 (<xref ref-type="bibr" rid="bib33">Hockly et al., 2003</xref>; <xref ref-type="bibr" rid="bib24">Gardian et al., 2005</xref>; <xref ref-type="bibr" rid="bib89">Thomas et al., 2008</xref>; <xref ref-type="bibr" rid="bib68">Mielcarek et al., 2011</xref>; <xref ref-type="bibr" rid="bib38">Jia et al., 2012a</xref>; <xref ref-type="bibr" rid="bib39">Jia et al., 2012b</xref>; <xref ref-type="bibr" rid="bib40">Jia et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Chopra et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Suelves et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Siebzehnrübl et al., 2018</xref>). The impact on transcriptional dysregulation was investigated in a number of these studies, with most focusing on specific candidate genes. Overall, these studies revealed relatively modest reversal of transcriptional changes elicited by the mutant transgenes, though HDAC inhibitor 4b was found to normalize ~1/3 of genes altered in R6/2 mice harboring 300 CAG repeats (<xref ref-type="bibr" rid="bib89">Thomas et al., 2008</xref>). Our data indicate that HDAC inhibitors with activity against HDAC2 would have the potential to reverse some of the early transcriptional changes elicited by an expanded CAG mutation. However, our results also indicate a complex relationship between the expanded CAG repeat mutation and <italic>Hdac2</italic>, with potential implications for therapies directed at HDAC2 inhibition.</p><p>We demonstrate here that <italic>Hdac2</italic> and <italic>Hdac3</italic> are enhancers of CAG expansion in MSNs. It is important to note that neither knockout of <italic>Hdac2</italic> nor <italic>Hdac3</italic> had a large impact on CAG expansion, in contrast to a number of MMR genes that are fundamental drivers of this process and whose knockouts eliminate expansion (<xref ref-type="bibr" rid="bib99">Wheeler et al., 2003</xref>; <xref ref-type="bibr" rid="bib22">Dragileva et al., 2009</xref>; <xref ref-type="bibr" rid="bib80">Pinto et al., 2013</xref>). Our results are consistent with those of Suelves et al. in which treatment of <italic>Htt</italic><sup>Q111</sup> mice with HDAC inhibitor RGFP966, resulted in a slight reduction in striatal CAG expansion (<xref ref-type="bibr" rid="bib87">Suelves et al., 2017</xref>). <italic>HDAC3</italic> and<italic> HDAC5</italic> enhanced CAG expansion in a selectable human astrocyte cell-based assay, whereas <italic>HDAC9</italic> suppressed expansions (<xref ref-type="bibr" rid="bib18">Debacker et al., 2012</xref>; <xref ref-type="bibr" rid="bib23">Gannon et al., 2012</xref>). A role for <italic>HDAC2</italic> was not implicated in this system, based on differential effects of HDAC inhibitors with selectivity towards HDACs 1 and 2 or HDAC3 (<xref ref-type="bibr" rid="bib18">Debacker et al., 2012</xref>). Further studies are needed to understand the mechanism(s) by which <italic>Hdac2</italic> and <italic>Hdac3</italic> enhance CAG expansion in HD mice. There is evidence that CAG instability may depend on the chromatin environment in the vicinity of the repeat (<xref ref-type="bibr" rid="bib58">Libby et al., 2003</xref>; <xref ref-type="bibr" rid="bib59">Libby et al., 2008</xref>; <xref ref-type="bibr" rid="bib77">Nestor and Monckton, 2011</xref>; <xref ref-type="bibr" rid="bib78">Neto et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Goula et al., 2012</xref>; <xref ref-type="bibr" rid="bib21">Dion and Wilson, 2009</xref>), and both HDAC2 and HDAC3 play roles in regulating genome stability via effects on histone acetylation and recruitment or accessibility of DNA repair proteins (<xref ref-type="bibr" rid="bib70">Miller et al., 2010</xref>; <xref ref-type="bibr" rid="bib5">Bhaskara et al., 2010</xref>). Therefore, it is possible that <italic>Hdac2</italic> or <italic>Hdac3</italic> modify CAG instability by altering chromatin structure close to the CAG repeat tract. We did observe a small reduction in huntingtin mRNA in <italic>Hdac2</italic> knockout mice (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>) suggesting a possible alteration in transcriptional dynamics at the <italic>Htt</italic> locus that may reflect an underlying change in chromatin structure. Our data argue, at least for the <italic>Hdac2</italic> KO, against altered transcription of genes encoding DNA repair proteins underlying the reduction in somatic expansion. However, it is possible that changes in acetylation of DNA repair proteins could lead to their altered activity (<xref ref-type="bibr" rid="bib15">Chatterjee et al., 2012</xref>; <xref ref-type="bibr" rid="bib17">Choudhary et al., 2009</xref>; <xref ref-type="bibr" rid="bib104">Zhang et al., 2014</xref>; <xref ref-type="bibr" rid="bib82">Radhakrishnan et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Piekna-Przybylska et al., 2016</xref>; <xref ref-type="bibr" rid="bib105">Zhang et al., 2019</xref>). This was proposed as a plausible mechanism by which <italic>HDAC3</italic> and <italic>HDAC5</italic> enhance CAG expansion in a selectable human astrocyte cell-based assay, in part based on epistasis experiments showing that <italic>HDAC3</italic> and <italic>HDAC5</italic> act in the same pathway as <italic>MSH2</italic> (<xref ref-type="bibr" rid="bib18">Debacker et al., 2012</xref>; <xref ref-type="bibr" rid="bib23">Gannon et al., 2012</xref>). It was recently suggested that HDAC3 might modify CAG instability by altering the subcellular localization of MSH3 (<xref ref-type="bibr" rid="bib101">Williams et al., 2020</xref>). Understanding the interplay between HDACs and DNA repair proteins controlling CAG repeat dynamics may provide important insight into the regulation of these DNA repair proteins and potentially novel ways in which to intervene in the process of CAG expansion.</p><p>MSN-specific <italic>Hdac2</italic> knockout also reduced nuclear huntingtin intensity and inclusion phenotypes, consistent with decreased striatal CAG expansions and the known sensitivity of these phenotypes to repeat length and to modification of somatic instability (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>; <xref ref-type="bibr" rid="bib22">Dragileva et al., 2009</xref>; <xref ref-type="bibr" rid="bib80">Pinto et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Wheeler et al., 2002</xref>). We did not observe a significant effect of <italic>Hdac3</italic> knockout on nuclear huntingtin intensity in the few mice analyzed and would likely need larger numbers of mice to observe a reduction in this phenotype that might be predicted by the lower striatal CAG repeat lengths in <italic>Hdac3</italic> KO mice. Most studies of pharmacological or genetic inhibition of class I HDACs in HD mouse models have reported a lack of impact on nuclear inclusions or aggregation (<xref ref-type="bibr" rid="bib33">Hockly et al., 2003</xref>; <xref ref-type="bibr" rid="bib24">Gardian et al., 2005</xref>; <xref ref-type="bibr" rid="bib40">Jia et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Moumné et al., 2012</xref>), although HDAC inhibitor 4b reduced aggregates in the N171-82Q model (<xref ref-type="bibr" rid="bib39">Jia et al., 2012b</xref>). We suggest that <italic>Hdac2</italic> knockout modifies nuclear intensity and inclusion phenotypes in <italic>Htt</italic><sup>Q111</sup> mice at least in part as a consequence of reduced CAG expansion in MSNs. Other mechanisms are also plausible, however, effects on mutant huntingtin levels themselves are not supported by our data. In contrast, the modest reduction in CAG expansion caused by the <italic>Hdac2</italic> knockout is unlikely to explain the reversal of transcriptional dysregulation elicited by the <italic>Htt</italic><sup>Q111</sup> allele, in which gene expression levels that can be distinguished between wild-type and <italic>Htt</italic><sup>Q111/+</sup> mice appear effectively normalized to wild-type in <italic>Htt</italic><sup>Q111/+</sup> mice harboring the <italic>Hdac2</italic> knockout mutation.</p><p>In summary, we have tested whether <italic>Hdac2</italic> and <italic>Hdac3</italic> are modifiers of different aspects of the HD pathogenic process in MSNs that are both inherently prone to CAG repeat expansion and specifically vulnerable in the disease process. The results of this study indicate moderate effects of these genes on CAG expansion, which in humans drives the rate of disease onset, and for <italic>Hdac2,</italic> on downstream molecular and cellular phenotypes that may be important in cellular toxicity mechanisms.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mouse lines and breeding</title><p><italic>Htt</italic><sup>Q111</sup> knock-in mice used in this study were on a C57BL/6J background (<xref ref-type="bibr" rid="bib54">Lee et al., 2011</xref>) and were maintained by breeding heterozygous males to C57BL/6J wild-type females from The Jackson Laboratory (Bar Harbor, ME). D9-Cre transgenic mice contain a genomic fragment, comprising about 2 kb of 5´ regulatory sequence, the endogenous ATG, and some of the introns and exons of the mouse <italic>Ppp1r1b</italic> gene encoding DARPP-32, driving the expression of Cre recombinase in MSNs after 5–6 weeks of age (<xref ref-type="bibr" rid="bib8">Bogush et al., 2005</xref>). These mice were maintained on a C57BL/6J background. Mice harboring conditional ‘floxed’ <italic>Hdac2</italic> or <italic>Hdac3</italic> alleles contained <italic>loxP</italic> sites upstream of exon2/downstream of exon 4 of the <italic>Hdac2</italic> gene (<xref ref-type="bibr" rid="bib73">Montgomery et al., 2007</xref>) and upstream of exon 11/downstream of exon 14 of <italic>Hdac3</italic> gene (<xref ref-type="bibr" rid="bib74">Montgomery et al., 2008</xref>). Both floxed mouse lines were originally on a mixed C57BL/6/129SeEv background and subsequently maintained by breeding heterozygous males or females to C57BL/6J wild-type mice from The Jackson Laboratory.</p><p>Detailed breeding schemes are shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. Mice carrying conditional floxed <italic>Hdac2</italic> or <italic>Hdac3</italic> alleles were crossed with <italic>Htt</italic><sup>Q111</sup> mice and, in a separate cross, with D9-Cre mice. The progeny from the two crosses were bred together to obtain <italic>Htt<sup>+/+</sup></italic> and <italic>Htt</italic><sup>Q111/+</sup> mice with or without the <italic>Hdac2</italic> (or <italic>Hdac3</italic>) floxed allele and/or Cre transgene. Mice harboring either no floxed <italic>Hdac</italic> alleles in the presence of Cre or one, two, or no floxed alleles in the absence of Cre were wild-type with respect to HDAC expression and are called <italic>Hdac2</italic> WT or <italic>Hdac3</italic> WT. Mice homozygous for the floxed <italic>Hdac</italic> alleles and expressing Cre are called <italic>Hdac2</italic> KO or <italic>Hdac3</italic> KO. In these mice the <italic>Hdac2</italic> or <italic>Hdac3</italic> alleles are deleted in MSNs and do not express HDAC2 or HDAC3 in MSNs. In a parallel cross, <italic>Htt</italic><sup>Q111/+</sup> mice were crossed with D9-Cre mice to generate <italic>Htt</italic><sup>+/+</sup> and <italic>Htt</italic><sup>Q111/+</sup> mice with or without the Cre transgene, with the purpose of testing the effect of Cre expression alone on the phenotypes being measured. Note that mice were not fully backcrossed to C57BL/6J prior to the crosses with B6J.D9-Cre mice and B6J.<italic>Htt</italic><sup>Q111</sup> mice. However, analyses of our RNA-seq data showed that all mice had a B6 haplotype for the <italic>Mlh1</italic> gene, where genetic variation between B6 and 129 strains is known to associate with CAG instability (<xref ref-type="bibr" rid="bib80">Pinto et al., 2013</xref>).</p><p>Numbers of mice used in this study were gauged based on extensive prior knowledge of cellular and molecular phenotypes elicited by the <italic>Htt<sup>Q111</sup></italic> allele and their genetic modification (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>; <xref ref-type="bibr" rid="bib80">Pinto et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref>), and incorporated controlling for inherited CAG repeat length (<xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>). In all the mouse experiments, ‘N’=number of mice (biological replicates).</p></sec><sec id="s4-2"><title>Genotyping</title><p>Genomic DNA was extracted from tail or ear biopsies taken at weaning for genotyping, or from adult striatum for the CAG repeat instability assay (Qiagen DNeasy blood and tissue kit). Genotypes were further confirmed in striatal DNA. CAG sizing was carried out as previously described, using human <italic>HTT</italic> CAG-specific primers (<xref ref-type="bibr" rid="bib22">Dragileva et al., 2009</xref>). PCR products were resolved using the AB13730xl automated DNA analyzer (Applied Biosystems). GeneMapper v3.7 with GeneScan 500-LIZ as internal size standard was used to assign repeat size, defined as the highest peak in the GeneMapper trace. All runs included the same control DNAs of known <italic>HTT</italic> CAG repeat size. We incorporated a novel PCR genotyping assay that distinguished knock-in and mouse wild-type alleles using primers flanking the 5’ <italic>loxP</italic> site remaining after excision of the floxed neomycin resistance cassette used in the original gene targeting (<xref ref-type="bibr" rid="bib100">White et al., 1997</xref>; <xref ref-type="bibr" rid="bib96">Wheeler et al., 1999</xref>). The assay included 0.5 μM forward primer (5´ <named-content content-type="sequence">TCTGATACAGCCCATGCTGA</named-content>), 0.5 μM reverse primer (5´ <named-content content-type="sequence">CTGAGTTCAATCCCTGCATTT</named-content>) and 2x Phusion High-Fidelity PCR Master Mix with HF Buffer (New England Biolabs). Cycling conditions were 98°C for 30 s; 30 cycles of 98°C for 5 s, 62°C for 15 s, 72°C for 20 s; 72°C for 10 min, generating a 129 bp product from the wild-type allele and a 240 bp product from the <italic>Htt</italic><sup>Q111</sup> knock-in allele.</p><p>D9-Cre mice were genotyped as described (<xref ref-type="bibr" rid="bib8">Bogush et al., 2005</xref>). For <italic>Hdac2</italic> genotyping, wild-type and floxed alleles were detected by a triplex PCR assay. The forward primer upstream of 5´ <italic>loxP</italic> site (HDAC2WT-F: 5´ <named-content content-type="sequence">GGCCAAGCATATTCAAACCACC</named-content>) and the reverse primer between the 5´ <italic>loxP</italic> site and exon 2 (HDAC2-REV: 5´ <named-content content-type="sequence">GTCAGCTAGTAGTGCTTCTTGG</named-content>) generated a 226 bp product for the wild type <italic>Hdac2</italic> allele, while the forward primer within the 5´ <italic>loxP</italic> site (HDAC2MUT-F; 5´ <named-content content-type="sequence">GTCCCTCGACCTGCAGGAATTC</named-content>) and the same reverse primer gave a 146 bp PCR product for the floxed allele. The PCR assay contained 0.2 μM each of HDAC2WT-F and HDAC2MUT-F primers, 0.4 μM of HDAC2-REV primer, 0.025 units GoTaq DNA polymerase (Promega), 5x GoTaq buffer (Promega), additional MgCl<sub>2</sub> (5 mM), and dNTP mixture (0.05 mM each). Cycling conditions were 94°C for 2 min; 30 cycles of 94°C for 15 s, 60°C for 30 s, 72°C for 40 s; 72°C for 5 min. To detect specifically the deleted <italic>Hdac2</italic> allele, a different forward primer upstream of 5´ <italic>loxP</italic> site (5´ <named-content content-type="sequence">GTGGGAAGCATGGCAGCATGC</named-content>) and reverse primer downstream of the 3´ <italic>loxP</italic> site, between exons 4 and 5 (5´ <named-content content-type="sequence">GCCTTCTAAGAACCCCAGGGAAC</named-content>) were used, resulting in a 550 bp product upon Cre-mediated excision. PCR conditions were 0.2 μM of each primer, 0.025 units GoTaq DNA polymerase (Promega), 5x GoTaq buffer (Promega), additional MgCl<sub>2</sub> (5 mM), and dNTP mixture (0.05 mM each). Cycling conditions were 94°C for 2 min; 30 cycles of 94°C for 15 s, 68°C for 30 s, 72°C for 40 s; 72°C for 5 min. For <italic>Hdac3</italic> genotyping, a triplex assay was used to detect all three alleles, with one forward/reverse pair of primers up- and downstream from the 5´ <italic>loxP</italic> site (HDAC3-5´-loxP-F: 5´ <named-content content-type="sequence">GCTTGGTAGCCAGCCAGCTTAG</named-content>, and HDAC3-5´-loxP-R: 5´ <named-content content-type="sequence">CATGTGACCCCAGACATGACTGG</named-content>), and the third (reverse) primer downstream of the 3´ <italic>loxP</italic> site (HDAC3-3´-loxP-R: 5´ <named-content content-type="sequence">CAGTCCATGCCTATAATCCCAGC</named-content>). This assay produced a 350 bp product for the wild-type <italic>Hdac3</italic> allele, a 450 bp product for the ‘floxed’ allele (both products were from HDAC3-5´-loxP-F and HDAC3-5´-loxP-R primers), and a 650 bp product for the deleted <italic>Hdac3</italic> allele after Cre-mediated excision (from HDAC3-5´-loxP-F and HDAC3-3´-loxP-R primers). The PCR assay contained 0.2 μM each of the three primers, 0.025 units GoTaq DNA polymerase (Promega), 5x GoTaq buffer (Promega), additional MgCl<sub>2</sub> (5 mM), and dNTP mixture (0.05 mM each). Cycling conditions were 94°C for 2 min; 30 cycles of 94°C for 15 s, 60°C for 30 s, 72°C for 40 s; 72°C for 5 min.</p></sec><sec id="s4-3"><title>Measurement of CAG expansion</title><p>Expansion indices in striatum were quantified from GeneMapper traces of PCR-amplified <italic>HTT</italic> CAG repeat, as described previously (<xref ref-type="bibr" rid="bib53">Lee et al., 2010</xref>), taking into account only expansion peaks to the right of the highest peak (main allele) and without filtering peaks based on relative peak height. Although there is intrinsic PCR bias in analyses of instability from ‘bulk DNA’, this nevertheless allows quantification of subtle differences in repeat instability, and metrics derived from the GeneMapper traces correlate well with repeat length distributions obtained from analyses of single molecules (<xref ref-type="bibr" rid="bib53">Lee et al., 2010</xref>). Briefly, normalized peak heights were calculated by dividing each expansion peak height by the sum of the heights of the main allele plus all expansion peaks, the change in CAG length of each expansion peak from the main allele was determined, each normalized peak height was multiplied by the CAG change from the main allele, and these values were summed to generate an expansion index that represents the mean positive CAG repeat length change in the population of cells being analyzed.</p></sec><sec id="s4-4"><title>Immunohistochemistry</title><p>Primary antibodies used were: mouse monoclonal anti-huntingtin (mAb5374, Millipore), rabbit polyclonal anti-histone H3 (ab1791, Abcam), rabbit polyclonal anti-HDAC2 (ab7029, Abcam), rabbit monoclonal anti-HDAC3 (clone Y415; formerly available from Millipore), mouse monoclonal anti-DARPP-32 (D32-6a; a kind gift from Dr. Angus Nairn) and rabbit polyclonal anti-DARPP-32 (ab40801, Abcam).</p><p>Immunostaining was performed on 8 μm coronal sections of periodate-lysine-paraformaldehyde (PLP)-perfused and -post-fixed, paraffin-embedded brains. Perfusion and tissue processing/embedding methods have been described previously (<xref ref-type="bibr" rid="bib97">Wheeler et al., 2000</xref>). For most mouse cohorts, one hemisphere of the brain was embedded for sectioning and the other one was used for dissection of striatum for analysis of somatic instability. Sections chosen for immunostaining were aligned with respect to their anterior/posterior location in the brain. The sections were deparaffinized, rehydrated and subjected to heat-mediated epitope retrieval (Na-citrate buffer pH 6.0) followed by quenching of endogenous peroxidase with 0.3% H<sub>2</sub>O<sub>2</sub>/methanol for 30 min at room temperature (RT), and blocked in 3% normal horse serum (NHS) in Tris-buffered saline (TBS) for 1 hr at room temperature. Immunostaining for diffuse nuclear huntingtin, huntingtin inclusions and histone H3 was described in detail (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>). For double staining with mouse anti-DARPP-32/rabbit anti-HDAC3 antibodies sections were incubated with both primary antibodies (D32-6a at 1:200 and Y415 at 1:2000 in 1% NHS/TBS) overnight at 4°C, followed by sequential amplification of HDAC3 and DARPP-32 signal. First, HDAC3 signal was amplified using the TSA Biotin System (Perkin Elmer) according to manufacturer’s instructions and quenching of HRP activity (0.1% sodium azide/0.3% H<sub>2</sub>O<sub>2</sub> in TBS for 30 min at RT) was performed before the addition of streptavidin-Alexa Fluor 555. Then, DARPP-32 signal was amplified using TSA kit #2 (Invitrogen/Thermo Fisher Scientific) by incubating with goat anti mouse-HRP at 1:100 for 1 hr at RT and then with Tyramide-Alexa Fluor-488 at 1:100 in the amplification diluent (all provided with the TSA kit #2), for 25 min at RT. For double staining with mouse anti-DARPP-32/rabbit anti-HDAC2 antibodies sections were incubated with both primary antibodies (D32-6a at 1:200 and ab7029 at 1:1000 in 1% NHS/TBS) overnight at 4°C. DARPP-32 signal was amplified as described above, and HDAC2 signal was detected with donkey anti-rabbit Alexa Fluor 555-conjugated secondary antibody (Invitrogen/Thermo Fisher Scientific, 1:1000) added as the last step after DARPP-32 signal amplification. For staining with rabbit anti-DARPP-32 antibody sections were incubated with ab40801 at 1:750 at 4°C overnight, followed by donkey anti-rabbit Alexa Fluor 488 secondary antibody.</p><p>All slides were mounted in ProLong Gold antifade reagent (Invitrogen/Thermo Fisher Scientific). Fluorescent microscopy was performed with a Zeiss Axioskop two microscope equipped with AxioCamMRm camera and AxioVision 4.6 image acquisition software, using Plan Apochromat 20x/0.8 M27 or Plan Neofluar 40x/0.75 Ph2 objectives. Images that were to be quantified and compared were taken with the same exposure times.</p></sec><sec id="s4-5"><title>Quantification of immunohistochemical data</title><p>Quantification was performed as described previously (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>), using CellProfiler 3.0.0 image analysis software (<xref ref-type="bibr" rid="bib14">Carpenter et al., 2006</xref>). Briefly, diffuse nuclear huntingtin immunostaining was quantified in four 40x striatal images per mouse (one medial, located next to the lateral ventricle, and one lateral, located at the end of external capsule; from two consecutive sections). Total (integrated) intensity of mAb5374 staining was measured in all mAb5374-positive nuclei in each image and normalized by the total number of nuclei (as determined by the number of all histone H3-positive nuclei) in the same image. The resulting value, representing the mean intensity of mAb5374 staining per nucleus, was averaged from four images for each mouse. The number of nuclear huntingtin inclusions (total per image) was quantified, blind to genotype, with CellProfiler 3.0.0 in two 20x images per mouse (taken mid-striatum from two consecutive coronal sections), normalized by the total number of histone-H3-positive nuclei in each image (taken as 100%), and resulting percentages were averaged over these two images for each mouse. Number of DARPP-32-positive cells and total integrated intensity of DARPP-32 staining in DARPP-32-positive cells were also quantified with CellProfiler 3.0.0 in four 40x images per mouse, taken in the same striatal locations as for diffuse nuclear huntingtin immunostaining quantification. Total integrated intensity was normalized by the number of DARPP-32-positive cells in each image to obtain mean integrated intensity values. Both mean integrated intensity of DARPP-32 staining and the number of DARPP32-positive cells were averaged from four images for each mouse.</p></sec><sec id="s4-6"><title>Western blot analysis</title><p>Striatal extracts were prepared as described previously (<xref ref-type="bibr" rid="bib49">Kovalenko et al., 2012</xref>). For detection of huntingtin protein, 90 μg of striatal extracts were resolved by SDS-PAGE in Novex 3–8% Tris-acetate gels (Invitrogen/Thermo Fisher Scientific) and transferred to 0.45 μm nitrocellulose membrane (Bio-Rad) in Transfer Buffer (Boston BioProducts) at 100 V for 72 min. After blocking with 5% non-fat milk, HTT protein was detected using mAb2166 antibody (Millipore) at 1:1000 in 5% non-fat milk/TBS/0.05% Tween-20 and visualized with ECL kit (ThermoScientific).</p><p>For HDAC2 and HDAC1, 40 μg of striatal extracts were resolved on 12% Bis-Tris gels (Invitrogen/Thermo Fisher Scientific) and transferred in Transfer Buffer with 10% methanol, 0.025% SDS at 110 V for 75 min. The membranes were blocked with 5% non-fat milk in TBS/0.05% Tween-20 and incubated with anti-HDAC2 H3159 antibody (Sigma) at 1:10000 or anti-HDAC1 ab31263 (Abcam) at 1:2000 in 1% non-fat milk/TBS/0.05% Tween-20 and developed with ECL kit.</p><p>For detection of acetylated histones H3AcK9 and H4AcK12, 35 μg of striatal extracts were resolved on 12% Bis-Tris gels (Invitrogen/Thermo Fisher Scientific) and transferred in Transfer Buffer with 10% methanol, 0.025% SDS at 150 V for 75 min. The membranes were blocked as above and incubated with anti-H3AcK9 ab10812 (Abcam) at 1:500 or anti-H4AcK12 #04–119 (Millipore) at 1:500 in 1% non-fat milk/TBS/0.01% Tween-20 and developed with ECL kit.</p><p>Total histone H3 was detected after stripping and re-probing the same membrane with ab1791 (Abcam) at 1:2000 in 1% non-fat milk/TBS/0.05% Tween-20.</p><p>For detection of MSH3, SDS-PAGE and transfer was as for HDAC1 and HDAC2 (above). The membranes were blocked as above and incubated with anti-MSH3 mouse monoclonal antibody 2F11 -a kind gift from Glen Morris and Ian Holt (<xref ref-type="bibr" rid="bib34">Holt et al., 2011</xref>)- at 1:300 in 5% non-fat milk/TBS/0.05% Tween-20.</p><p>For quantification of Western blot data the density of protein bands of interest was measured with Quantity One software (Bio-Rad) with local background subtraction and normalized by the total amount of protein per corresponding lane as measured by the density of the entire lane stained by Novex reversible protein stain (Invitrogen/Thermo Fisher Scientific). Normalized values (one per mouse) were averaged over each genotype group.</p></sec><sec id="s4-7"><title>Selectable cell-based assay for CAG repeat contractions</title><p>The selectable assay for repeat contractions, based on insertion of a CAG repeat into an intron of an <italic>HPRT</italic> minigene, was performed in FLAH25 cells as described (<xref ref-type="bibr" rid="bib37">Hubert et al., 2011</xref>). Cell maintenance, inhibitor treatment regimen, and selection for resistant colonies in HAT medium (0.1 mM hypoxanthine, 0.4 µM aminopterin, and 16 µM thymine) were as described (<xref ref-type="bibr" rid="bib37">Hubert et al., 2011</xref>).~4.5×10<sup>6</sup> cells were plated and the number of HPRT<sup>+</sup> colonies was adjusted by cell survival ([number of positive colonies] / [number of plated cells multiplied by plating efficiency]). The effect of inhibitors on CAG repeat contractions was expressed as fold change of the adjusted number of positive colonies over DMSO.</p></sec><sec id="s4-8"><title>RNA-seq library preparation and sequencing</title><p>RNA was isolated from striatal tissues of 36 5-month mice of four genotype groups: <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT (N = 9: six males, three females), <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> WT (N = 7: four males, three females), <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> ΚO (N = 9: five males, four females) and <italic>Htt</italic><sup>Q111/+</sup> <italic>Hdac2</italic> ΚO (N = 11: eight males, three females) lines using TRIzol reagent. Briefly, pelleted cells were resuspended in TRIzol reagent and then extracted with chloroform, followed by isopropanol precipitation of RNA from the aqueous phase and three 70% ethanol washes. RNA pellets were solubilized in 30–50 µl of RNase-free water (Ambion, AM9937). RNA quality was assessed using the Agilent Bioanalyzer TapeStation 2200 (Agilent Technologies, Santa Clara, CA). In total, 36 RNA-seq libraries were prepared using the Illumina TruSeq Stranded mRNA Sample Prep Kit. Each library in this study included 1 ul of a 1:10 dilution of ERCC RNA Control Spike-Ins (Ambion) that were added from one of two mixes, each containing the same 92 synthetic RNA standards of known concentration and sequence. These synthetic RNAs cover a 10<sup>6</sup> range of concentration, as well as varying in length and GC content to allow for validation of dose response and the fidelity of the procedure in downstream analyses (<xref ref-type="bibr" rid="bib41">Jiang et al., 2011</xref>). Libraries were multiplexed, pooled, and sequenced on multiple lanes of an Illumina HiSeq2000, generating median 40.7M paired-end reads per library of 75 bp.</p></sec><sec id="s4-9"><title>RNA-seq data processing and analysis</title><p>Quality checking of sequence reads was assessed using fastQC (v. 0.10.1) (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc">http://www.bioinformatics.babraham.ac.uk/projects/fastqc</ext-link>), blind to genotype. Sequence reads were aligned to the mouse reference genome (GRCm38, Ensembl build v. 75) using GSNAP (version 2015-06-23) with parameters ‘-a off -N 1 –pairexpect=450 -B 3 –query-unk-mismatch=1’ (<xref ref-type="bibr" rid="bib102">Wu and Nacu, 2010</xref>). Gene level counts were tabulated using BedTools’s multibamcov algorithm on unique alignments for each library at all Ensembl genes (GRCm38 v.75). Based on quality checking of alignments assessed by custom scripts utilizing PicardTools (<ext-link ext-link-type="uri" xlink:href="https://broadinstitute.github.io/picard/">https://broadinstitute.github.io/picard/</ext-link>), RNASeQC (<xref ref-type="bibr" rid="bib19">DeLuca et al., 2012</xref>), RSeQC (<xref ref-type="bibr" rid="bib95">Wang et al., 2012</xref>) and SamTools (<xref ref-type="bibr" rid="bib57">Li et al., 2009</xref>), one male sample with genotype <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT was identified as an outlier and thus excluded from further analysis as this sample showed high intergenic (25%), intronic (23%), duplication rates (57%) and low exonic rates (53%), which indicated DNA contamination in this sample. Analysis of ERCC spike-ins as described (<xref ref-type="bibr" rid="bib6">Blumenthal et al., 2014</xref>) estimated the expression threshold for detection to be at least six uniquely mapped reads. Genes smaller than 250 nt in length and tRNA and rRNA genes were removed from further analyses. Principal component analysis (PCA) of the remaining 35 samples was performed using a Bioconductor package, DESeq2 (v. 1.18.1) (<xref ref-type="bibr" rid="bib65">Love et al., 2014</xref>) relying on regularized log-transformed counts after keeping genes expressed in all the samples from at least one genotype group with at least six counts. Differentially expressed genes (DEGs) in five pair-wise comparisons <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> KO vs. <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT [contrast 1], <italic>Htt</italic><sup>Q111/+</sup> <italic>Hdac2</italic> KO vs. <italic>Htt</italic><sup>Q111/+</sup> <italic>Hdac2</italic> WT [contrast 2], <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> WT vs. <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT [contrast 3], <italic>Htt</italic><sup>Q111/+</sup> <italic>Hdac2</italic> KO vs. <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> KO [contrast 4] and <italic>Htt</italic><sup>Q111/+</sup> <italic>Hdac2</italic> KO vs. <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT [contrast 5], were identified by edgeR’s quasi-likelihood F test (v. 3.12) (<xref ref-type="bibr" rid="bib83">Robinson et al., 2010</xref>) with surrogate variables (SVs) accounting for batch effects and unknown factors in data, which were determined by Bioconductor Package SVA (v. 3.18) (<xref ref-type="bibr" rid="bib55">Leek et al., 2012</xref>; <xref ref-type="bibr" rid="bib56">Leek, 2014</xref>). To this end, SVA was applied to all 35 RNAseq samples separately for each comparison of interest where the full model was mod = ~ 0 + genotype_group, while the null model was mod0 = ~ 1, analyzing genes that passed the expression detection threshold (≥ 6 counts), in at least one genotype group samples in a given comparison. As the number of analyzed genes differed from comparison to comparison, SVA identified a distinct set of SVs for each comparison, although they were highly similar between comparisons (average correlation = 0.99). DEGs were defined at two statistical significance levels: less stringent, using a nominal p &lt; 0.05 cut-off, and more stringent, using a false discovery rate (FDR) cut-off of &lt; 0.05, calculated based on the Benjamini-Hochberg procedure (<xref ref-type="bibr" rid="bib3">Benjamini and Hochberg, 1995</xref>). KEGG pathway and gene ontology (GO) enrichments were performed using DAVID (v. 6.8) for DEGs at both p &lt; 0.05 and FDR &lt; 0.05 levels (<xref ref-type="bibr" rid="bib36">Huang et al., 2009</xref>). In doing so, lists of DEGs in either category of direction of dysregulation (upregulated, downregulated and both) for a given comparison were used as a query list, while a list of all the analyzed genes was treated as a background list. Differentially regulated pathways were also defined at less stringent (p&lt;0.05) and more stringent (FDR&lt;0.05) significance levels. We compared our differential expression results from the <italic>Htt</italic><sup>Q111/+</sup> <italic>Hdac2</italic> WT vs <italic>Htt<sup>+/+</sup> Hdac2</italic> WT comparison (contrast 3) with those from a comparison of 6 month <italic>Htt</italic><sup>Q111/+</sup> (4 female, 4 male) vs <italic>Htt<sup>+/+</sup></italic> (4 female, 4 male) striata using the RNA-Seq dataset described in <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref>. To this end, we reanalyzed the Langfelder RNA-Seq data employing the same EdgeR + SVA pipeline as in the present study (as above). 16,395 genes that passed our expression threshold (≥ 6 counts) in either all mutant or all control samples were analyzed. We compared DEGs identified in both studies at both p &lt; 0.05 and FDR &lt; 0.05 thresholds as above. To assess the statistical significance of overlaps between DEGs or enriched pathways between pairs of contrasts (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) we performed one-tailed Fisher’s Exact tests, commonly used to assess the statistical significance of overlap of two sets or enrichment of one set in other (overrepresentation). To identify genes where <italic>Hdac2</italic> knockout is either protective or exacerbates the effect of the <italic>Htt</italic><sup>Q111</sup> allele, we first compared DEGs (p &lt; 0.05) in contrast 3 (<italic>Htt</italic><sup>Q111/+</sup> vs. <italic>Htt</italic><sup>+/+</sup> in <italic>Hdac2</italic> WT background) with those in contrast 2 (<italic>Hdac2</italic> KO vs. WT in <italic>Htt</italic><sup>Q111/+</sup> background). Next, we performed 2-tailed unpaired t-tests on those shared DEGs to identify genes that were not significantly differentially expressed (p &gt; 0.05) between <italic>Htt</italic><sup>+/+</sup> <italic>Hdac2</italic> WT and <italic>Htt</italic><sup>Q111/+ </sup><italic>Hdac2</italic> KO. To assess the statistical significance of observing reduced relative expression (fold-change of <italic>Htt</italic><sup>Q111</sup> versus <italic>Htt</italic><sup>+/+</sup>) of the 29 commonly dysregulated genes shared between thus study and Langfelder et al. in the Hdac2 KO background compared to the Hdac2 WT background we performed a permutation test. To this end, we randomly selected 29 genes 100,000 times from 15,508 genes analyzed in both this study and Langfelder et al. In each iteration, we compared the absolute value of log2 fold-changes of genes between <italic>Htt</italic><sup>Q111/+</sup> and <italic>Htt</italic><sup>+/+</sup> genotypes in <italic>Hdac2</italic> KO and <italic>Hdac2</italic> WT backgrounds and assessed how many times the randomly selected 29 genes showed the observed effect, that is <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtext> </mml:mtext><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mn>2</mml:mn><mml:mi>F</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>H</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mn>2</mml:mn><mml:mtext> </mml:mtext><mml:mi>K</mml:mi><mml:mi>O</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&lt;</mml:mo><mml:mtext> </mml:mtext><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mn>2</mml:mn><mml:mi>F</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>H</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mn>2</mml:mn><mml:mtext> </mml:mtext><mml:mi>W</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> where <inline-formula><mml:math id="inf2"><mml:msubsup><mml:mrow><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mo>(</mml:mo><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mn>2</mml:mn><mml:mi>F</mml:mi><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mn>2</mml:mn> <mml:mi/><mml:mi>K</mml:mi><mml:mi>O</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:math></inline-formula> is absolute value of log2 fold-change of i<sup>th</sup> gene between <italic>Htt</italic><sup>Q111/+</sup> and <italic>Htt</italic><sup>+/+</sup> genotypes in <italic>Hdac2</italic> KO background. All analyses were run on R platforms (versions 3.2.2, 3.3.2, 3.4.3, 3.6).</p></sec><sec id="s4-10"><title>Statistical analyses</title><p>We performed statistical analyses to compare quantitative instability and mAb5374 phenotypes between genotype groups. As we were not testing the effect of age on these phenotypes, and as our datasets were well controlled for inherited CAG length, we performed two-tailed unpaired t-tests to compare mean values between two genotype groups at any one age. Statistical analyses relevant to the RNA-seq data analyses are described in the section above.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are very grateful to Dr. Michelle Ehrlich for providing the DARPP-32 Cre transgenic mice, and to Dr. Eric Olson for providing the <italic>Hdac2</italic> and <italic>Hdac3</italic> floxed mice. We would like to thank CHDI for providing the ‘allelic series’ RNA-seq data described in <xref ref-type="bibr" rid="bib51">Langfelder et al., 2016</xref>.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>DMF is a member of the scientific advisory board of Psy Therapeutics.</p></fn><fn fn-type="COI-statement" id="conf3"><p>SJH is a member of the scientific advisory board of Psy Therapeutics, Frequency Therapeutics and Souvien Therapeutics, and former member of the scientific advisory board of Rodin Therapeutics that is focused on HDAC2 inhibitors, none of whom were involved in the present study. SJH has also received speaking or consulting fees from Amgen, AstraZeneca, Biogen, Merck, Regenacy Pharmaceuticals, as well as sponsored research or gift funding from AstraZeneca, JW Pharmaceuticals, and Vesigen unrelated to the content of this manuscript. His financial interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies.</p></fn><fn fn-type="COI-statement" id="conf4"><p>VCW is a scientific advisory board member of Triplet Therapeutics, a company developing new therapeutic approaches to address triplet repeat disorders such Huntington's disease and Myotonic Dystrophy and of LoQus23 Therapeutics. Her financial interests in Triplet Therapeutics, were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Funding acquisition, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health under an approved protocol (2009N000216) of the Massachusetts General Hospital Subcommittee on Research Animal Care.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="scode1"><label>Source code 1.</label><caption><title>RNA-seq codes and data files.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-55911-code1-v2.zip"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>CAG lengths of mouse cohorts.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-55911-data1-v2.docx"/></supplementary-material><supplementary-material id="sdata2"><label>Source data 2.</label><caption><title>Differentially expressed genes.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-data2-v2.xlsx"/></supplementary-material><supplementary-material id="sdata3"><label>Source data 3.</label><caption><title>Pathway analyses.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-data3-v2.xlsx"/></supplementary-material><supplementary-material id="sdata4"><label>Source data 4.</label><caption><title>Rescue analysis.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55911-data4-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-55911-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>RNA-Seq data is deposited in GEO, under the accession number GSE148440.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kovalenko</surname><given-names>M</given-names></name><name><surname>Erdin</surname><given-names>S</given-names></name><name><surname>Andrew</surname><given-names>MA</given-names></name><name><surname>Claire</surname><given-names>J</given-names></name><name><surname>Shaughnessey</surname><given-names>M</given-names></name><name><surname>Hubert</surname><given-names>L</given-names></name><name><surname>Neto</surname><given-names>JL</given-names></name><name><surname>Stortchevoi</surname><given-names>A</given-names></name><name><surname>Fass</surname><given-names>DM</given-names></name><name><surname>Pinto</surname><given-names>RM</given-names></name><name><surname>Haggarty</surname><given-names>SJ</given-names></name><name><surname>Wilson</surname><given-names>JH</given-names></name><name><surname>Talkowski</surname><given-names>ME</given-names></name><name><surname>Wheeler</surname><given-names>VC</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE148440">GSE148440</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alenghat</surname> <given-names>T</given-names></name><name><surname>Osborne</surname> <given-names>LC</given-names></name><name><surname>Saenz</surname> <given-names>SA</given-names></name><name><surname>Kobuley</surname> <given-names>D</given-names></name><name><surname>Ziegler</surname> <given-names>CG</given-names></name><name><surname>Mullican</surname> <given-names>SE</given-names></name><name><surname>Choi</surname> <given-names>I</given-names></name><name><surname>Grunberg</surname> <given-names>S</given-names></name><name><surname>Sinha</surname> <given-names>R</given-names></name><name><surname>Wynosky-Dolfi</surname> <given-names>M</given-names></name><name><surname>Snyder</surname> <given-names>A</given-names></name><name><surname>Giacomin</surname> <given-names>PR</given-names></name><name><surname>Joyce</surname> <given-names>KL</given-names></name><name><surname>Hoang</surname> <given-names>TB</given-names></name><name><surname>Bewtra</surname> <given-names>M</given-names></name><name><surname>Brodsky</surname> <given-names>IE</given-names></name><name><surname>Sonnenberg</surname> <given-names>GF</given-names></name><name><surname>Bushman</surname> <given-names>FD</given-names></name><name><surname>Won</surname> <given-names>KJ</given-names></name><name><surname>Lazar</surname> <given-names>MA</given-names></name><name><surname>Artis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis</article-title><source>Nature</source><volume>504</volume><fpage>153</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1038/nature12687</pub-id><pub-id pub-id-type="pmid">24185009</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ament</surname> <given-names>SA</given-names></name><name><surname>Pearl</surname> <given-names>JR</given-names></name><name><surname>Grindeland</surname> <given-names>A</given-names></name><name><surname>St Claire</surname> <given-names>J</given-names></name><name><surname>Earls</surname> <given-names>JC</given-names></name><name><surname>Kovalenko</surname> <given-names>M</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>Mysore</surname> <given-names>J</given-names></name><name><surname>Gusella</surname> <given-names>JF</given-names></name><name><surname>Lee</surname> <given-names>JM</given-names></name><name><surname>Kwak</surname> <given-names>S</given-names></name><name><surname>Howland</surname> <given-names>D</given-names></name><name><surname>Lee</surname> <given-names>MY</given-names></name><name><surname>Baxter</surname> <given-names>D</given-names></name><name><surname>Scherler</surname> <given-names>K</given-names></name><name><surname>Wang</surname> <given-names>K</given-names></name><name><surname>Geman</surname> <given-names>D</given-names></name><name><surname>Carroll</surname> <given-names>JB</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name><name><surname>Carlson</surname> <given-names>G</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name><name><surname>Price</surname> <given-names>ND</given-names></name><name><surname>Hood</surname> <given-names>LE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>913</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx006</pub-id><pub-id pub-id-type="pmid">28334820</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname> <given-names>Y</given-names></name><name><surname>Hochberg</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title><source>Journal of the Royal Statistical Society: Series B</source><volume>57</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1111/J.2517-6161.1995.TB02031.X</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benn</surname> <given-names>CL</given-names></name><name><surname>Butler</surname> <given-names>R</given-names></name><name><surname>Mariner</surname> <given-names>L</given-names></name><name><surname>Nixon</surname> <given-names>J</given-names></name><name><surname>Moffitt</surname> <given-names>H</given-names></name><name><surname>Mielcarek</surname> <given-names>M</given-names></name><name><surname>Woodman</surname> <given-names>B</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's disease</article-title><source>PLOS ONE</source><volume>4</volume><elocation-id>e5747</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0005747</pub-id><pub-id pub-id-type="pmid">19484127</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaskara</surname> <given-names>S</given-names></name><name><surname>Knutson</surname> <given-names>SK</given-names></name><name><surname>Jiang</surname> <given-names>G</given-names></name><name><surname>Chandrasekharan</surname> <given-names>MB</given-names></name><name><surname>Wilson</surname> <given-names>AJ</given-names></name><name><surname>Zheng</surname> <given-names>S</given-names></name><name><surname>Yenamandra</surname> <given-names>A</given-names></name><name><surname>Locke</surname> <given-names>K</given-names></name><name><surname>Yuan</surname> <given-names>JL</given-names></name><name><surname>Bonine-Summers</surname> <given-names>AR</given-names></name><name><surname>Wells</surname> <given-names>CE</given-names></name><name><surname>Kaiser</surname> <given-names>JF</given-names></name><name><surname>Washington</surname> <given-names>MK</given-names></name><name><surname>Zhao</surname> <given-names>Z</given-names></name><name><surname>Wagner</surname> <given-names>FF</given-names></name><name><surname>Sun</surname> <given-names>ZW</given-names></name><name><surname>Xia</surname> <given-names>F</given-names></name><name><surname>Holson</surname> <given-names>EB</given-names></name><name><surname>Khabele</surname> <given-names>D</given-names></name><name><surname>Hiebert</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hdac3 is essential for the maintenance of chromatin structure and genome stability</article-title><source>Cancer Cell</source><volume>18</volume><fpage>436</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2010.10.022</pub-id><pub-id pub-id-type="pmid">21075309</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumenthal</surname> <given-names>I</given-names></name><name><surname>Ragavendran</surname> <given-names>A</given-names></name><name><surname>Erdin</surname> <given-names>S</given-names></name><name><surname>Klei</surname> <given-names>L</given-names></name><name><surname>Sugathan</surname> <given-names>A</given-names></name><name><surname>Guide</surname> <given-names>JR</given-names></name><name><surname>Manavalan</surname> <given-names>P</given-names></name><name><surname>Zhou</surname> <given-names>JQ</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name><name><surname>Levin</surname> <given-names>JZ</given-names></name><name><surname>Ernst</surname> <given-names>C</given-names></name><name><surname>Roeder</surname> <given-names>K</given-names></name><name><surname>Devlin</surname> <given-names>B</given-names></name><name><surname>Gusella</surname> <given-names>JF</given-names></name><name><surname>Talkowski</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Transcriptional Consequences of 16p11.2 Deletion and Duplication in Mouse Cortex and Multiplex Autism Families</article-title><source>The American Journal of Human Genetics</source><volume>94</volume><fpage>870</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.05.004</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobrowska</surname> <given-names>A</given-names></name><name><surname>Paganetti</surname> <given-names>P</given-names></name><name><surname>Matthias</surname> <given-names>P</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6/2 mouse model of Huntington's disease</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e20696</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0020696</pub-id><pub-id pub-id-type="pmid">21677773</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogush</surname> <given-names>AI</given-names></name><name><surname>McCarthy</surname> <given-names>LE</given-names></name><name><surname>Tian</surname> <given-names>C</given-names></name><name><surname>Olm</surname> <given-names>V</given-names></name><name><surname>Gieringer</surname> <given-names>T</given-names></name><name><surname>Ivkovic</surname> <given-names>S</given-names></name><name><surname>Ehrlich</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>DARPP-32 genomic fragments drive cre expression in postnatal striatum</article-title><source>Genesis</source><volume>42</volume><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1002/gene.20118</pub-id><pub-id pub-id-type="pmid">15830379</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradner</surname> <given-names>JE</given-names></name><name><surname>West</surname> <given-names>N</given-names></name><name><surname>Grachan</surname> <given-names>ML</given-names></name><name><surname>Greenberg</surname> <given-names>EF</given-names></name><name><surname>Haggarty</surname> <given-names>SJ</given-names></name><name><surname>Warnow</surname> <given-names>T</given-names></name><name><surname>Mazitschek</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Chemical phylogenetics of histone deacetylases</article-title><source>Nature Chemical Biology</source><volume>6</volume><fpage>238</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1038/nchembio.313</pub-id><pub-id pub-id-type="pmid">20139990</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bragg</surname> <given-names>RM</given-names></name><name><surname>Coffey</surname> <given-names>SR</given-names></name><name><surname>Weston</surname> <given-names>RM</given-names></name><name><surname>Ament</surname> <given-names>SA</given-names></name><name><surname>Cantle</surname> <given-names>JP</given-names></name><name><surname>Minnig</surname> <given-names>S</given-names></name><name><surname>Funk</surname> <given-names>CC</given-names></name><name><surname>Shuttleworth</surname> <given-names>DD</given-names></name><name><surname>Woods</surname> <given-names>EL</given-names></name><name><surname>Sullivan</surname> <given-names>BR</given-names></name><name><surname>Jones</surname> <given-names>L</given-names></name><name><surname>Glickenhaus</surname> <given-names>A</given-names></name><name><surname>Anderson</surname> <given-names>JS</given-names></name><name><surname>Anderson</surname> <given-names>MD</given-names></name><name><surname>Dunnett</surname> <given-names>SB</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name><name><surname>Brooks</surname> <given-names>SP</given-names></name><name><surname>Price</surname> <given-names>ND</given-names></name><name><surname>Carroll</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt<sup>Q111/+</sup> model of Huntington's disease</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>41570</elocation-id><pub-id pub-id-type="doi">10.1038/srep41570</pub-id><pub-id pub-id-type="pmid">28176805</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broide</surname> <given-names>RS</given-names></name><name><surname>Redwine</surname> <given-names>JM</given-names></name><name><surname>Aftahi</surname> <given-names>N</given-names></name><name><surname>Young</surname> <given-names>W</given-names></name><name><surname>Bloom</surname> <given-names>FE</given-names></name><name><surname>Winrow</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Distribution of histone deacetylases 1-11 in the rat brain</article-title><source>Journal of Molecular Neuroscience</source><volume>31</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/BF02686117</pub-id><pub-id pub-id-type="pmid">17416969</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname> <given-names>NJ</given-names></name><name><surname>Johnson</surname> <given-names>R</given-names></name><name><surname>Zuccato</surname> <given-names>C</given-names></name><name><surname>Bithell</surname> <given-names>A</given-names></name><name><surname>Cattaneo</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease</article-title><source>Neurobiology of Disease</source><volume>39</volume><fpage>28</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2010.02.003</pub-id><pub-id pub-id-type="pmid">20170730</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carafa</surname> <given-names>V</given-names></name><name><surname>Nebbioso</surname> <given-names>A</given-names></name><name><surname>Altucci</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Histone deacetylase inhibitors: recent insights from basic to clinical knowledge &amp; patenting of anti-cancer actions</article-title><source>Recent Patents on Anti-Cancer Drug Discovery</source><volume>6</volume><fpage>131</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.2174/157489211793980088</pub-id><pub-id pub-id-type="pmid">21110829</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname> <given-names>AE</given-names></name><name><surname>Jones</surname> <given-names>TR</given-names></name><name><surname>Lamprecht</surname> <given-names>MR</given-names></name><name><surname>Clarke</surname> <given-names>C</given-names></name><name><surname>Kang</surname> <given-names>IH</given-names></name><name><surname>Friman</surname> <given-names>O</given-names></name><name><surname>Guertin</surname> <given-names>DA</given-names></name><name><surname>Chang</surname> <given-names>JH</given-names></name><name><surname>Lindquist</surname> <given-names>RA</given-names></name><name><surname>Moffat</surname> <given-names>J</given-names></name><name><surname>Golland</surname> <given-names>P</given-names></name><name><surname>Sabatini</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>CellProfiler: image analysis software for identifying and quantifying cell phenotypes</article-title><source>Genome Biology</source><volume>7</volume><elocation-id>R100</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2006-7-10-r100</pub-id><pub-id pub-id-type="pmid">17076895</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname> <given-names>S</given-names></name><name><surname>Senapati</surname> <given-names>P</given-names></name><name><surname>Kundu</surname> <given-names>TK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Post-translational modifications of lysine in DNA-damage repair</article-title><source>Essays in Biochemistry</source><volume>52</volume><fpage>93</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1042/bse0520093</pub-id><pub-id pub-id-type="pmid">22708566</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname> <given-names>V</given-names></name><name><surname>Quinti</surname> <given-names>L</given-names></name><name><surname>Khanna</surname> <given-names>P</given-names></name><name><surname>Paganetti</surname> <given-names>P</given-names></name><name><surname>Kuhn</surname> <given-names>R</given-names></name><name><surname>Young</surname> <given-names>AB</given-names></name><name><surname>Kazantsev</surname> <given-names>AG</given-names></name><name><surname>Hersch</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>LBH589, A hydroxamic Acid-Derived HDAC inhibitor, is neuroprotective in mouse models of Huntington's Disease</article-title><source>Journal of Huntington's Disease</source><volume>5</volume><fpage>347</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.3233/JHD-160226</pub-id><pub-id pub-id-type="pmid">27983565</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhary</surname> <given-names>C</given-names></name><name><surname>Kumar</surname> <given-names>C</given-names></name><name><surname>Gnad</surname> <given-names>F</given-names></name><name><surname>Nielsen</surname> <given-names>ML</given-names></name><name><surname>Rehman</surname> <given-names>M</given-names></name><name><surname>Walther</surname> <given-names>TC</given-names></name><name><surname>Olsen</surname> <given-names>JV</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Lysine acetylation targets protein complexes and Co-Regulates major cellular functions</article-title><source>Science</source><volume>325</volume><fpage>834</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1126/science.1175371</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debacker</surname> <given-names>K</given-names></name><name><surname>Frizzell</surname> <given-names>A</given-names></name><name><surname>Gleeson</surname> <given-names>O</given-names></name><name><surname>Kirkham-McCarthy</surname> <given-names>L</given-names></name><name><surname>Mertz</surname> <given-names>T</given-names></name><name><surname>Lahue</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Histone deacetylase complexes promote trinucleotide repeat expansions</article-title><source>PLOS Biology</source><volume>10</volume><elocation-id>e1001257</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001257</pub-id><pub-id pub-id-type="pmid">22363205</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLuca</surname> <given-names>DS</given-names></name><name><surname>Levin</surname> <given-names>JZ</given-names></name><name><surname>Sivachenko</surname> <given-names>A</given-names></name><name><surname>Fennell</surname> <given-names>T</given-names></name><name><surname>Nazaire</surname> <given-names>MD</given-names></name><name><surname>Williams</surname> <given-names>C</given-names></name><name><surname>Reich</surname> <given-names>M</given-names></name><name><surname>Winckler</surname> <given-names>W</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>RNA-SeQC: rna-seq metrics for quality control and process optimization</article-title><source>Bioinformatics</source><volume>28</volume><fpage>1530</fpage><lpage>1532</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts196</pub-id><pub-id pub-id-type="pmid">22539670</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dion</surname> <given-names>V</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Hubert</surname> <given-names>L</given-names></name><name><surname>Waterland</surname> <given-names>RA</given-names></name><name><surname>Wilson</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Dnmt1 deficiency promotes CAG repeat expansion in the mouse germline</article-title><source>Human Molecular Genetics</source><volume>17</volume><fpage>1306</fpage><lpage>1317</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddn019</pub-id><pub-id pub-id-type="pmid">18252747</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dion</surname> <given-names>V</given-names></name><name><surname>Wilson</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Instability and chromatin structure of expanded trinucleotide repeats</article-title><source>Trends in Genetics</source><volume>25</volume><fpage>288</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2009.04.007</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragileva</surname> <given-names>E</given-names></name><name><surname>Hendricks</surname> <given-names>A</given-names></name><name><surname>Teed</surname> <given-names>A</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>Lopez</surname> <given-names>ET</given-names></name><name><surname>Friedberg</surname> <given-names>EC</given-names></name><name><surname>Kucherlapati</surname> <given-names>R</given-names></name><name><surname>Edelmann</surname> <given-names>W</given-names></name><name><surname>Lunetta</surname> <given-names>KL</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes</article-title><source>Neurobiology of Disease</source><volume>33</volume><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2008.09.014</pub-id><pub-id pub-id-type="pmid">18930147</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gannon</surname> <given-names>AM</given-names></name><name><surname>Frizzell</surname> <given-names>A</given-names></name><name><surname>Healy</surname> <given-names>E</given-names></name><name><surname>Lahue</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>MutSβ and histone deacetylase complexes promote expansions of trinucleotide repeats in human cells</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>10324</fpage><lpage>10333</lpage><pub-id pub-id-type="doi">10.1093/nar/gks810</pub-id><pub-id pub-id-type="pmid">22941650</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardian</surname> <given-names>G</given-names></name><name><surname>Browne</surname> <given-names>SE</given-names></name><name><surname>Choi</surname> <given-names>DK</given-names></name><name><surname>Klivenyi</surname> <given-names>P</given-names></name><name><surname>Gregorio</surname> <given-names>J</given-names></name><name><surname>Kubilus</surname> <given-names>JK</given-names></name><name><surname>Ryu</surname> <given-names>H</given-names></name><name><surname>Langley</surname> <given-names>B</given-names></name><name><surname>Ratan</surname> <given-names>RR</given-names></name><name><surname>Ferrante</surname> <given-names>RJ</given-names></name><name><surname>Beal</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>556</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1074/jbc.M410210200</pub-id><pub-id pub-id-type="pmid">15494404</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium</collab></person-group><year iso-8601-date="2019">2019</year><article-title>CAG repeat not polyglutamine length determines timing of Huntington's Disease Onset</article-title><source>Cell</source><volume>178</volume><fpage>887</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.06.036</pub-id><pub-id pub-id-type="pmid">31398342</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geraerts</surname> <given-names>FC</given-names></name><name><surname>Snell</surname> <given-names>RG</given-names></name><name><surname>Faull</surname> <given-names>RL</given-names></name><name><surname>Williams</surname> <given-names>L</given-names></name><name><surname>Jacobsen</surname> <given-names>JC</given-names></name><name><surname>Reid</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Comparison of Huntington's disease CAG Repeat Length Stability in Human Motor Cortex and Cingulate Gyrus</article-title><source>Journal of Huntington's Disease</source><volume>5</volume><fpage>297</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.3233/JHD-160203</pub-id><pub-id pub-id-type="pmid">27716680</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glajch</surname> <given-names>KE</given-names></name><name><surname>Sadri-Vakili</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epigenetic mechanisms involved in Huntington's Disease Pathogenesis</article-title><source>Journal of Huntington's Disease</source><volume>4</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.3233/JHD-140134</pub-id><pub-id pub-id-type="pmid">25813218</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonitel</surname> <given-names>R</given-names></name><name><surname>Moffitt</surname> <given-names>H</given-names></name><name><surname>Sathasivam</surname> <given-names>K</given-names></name><name><surname>Woodman</surname> <given-names>B</given-names></name><name><surname>Detloff</surname> <given-names>PJ</given-names></name><name><surname>Faull</surname> <given-names>RLM</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>DNA instability in postmitotic neurons</article-title><source>PNAS</source><volume>105</volume><fpage>3467</fpage><lpage>3472</lpage><pub-id pub-id-type="doi">10.1073/pnas.0800048105</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorbunova</surname> <given-names>V</given-names></name><name><surname>Seluanov</surname> <given-names>A</given-names></name><name><surname>Mittelman</surname> <given-names>D</given-names></name><name><surname>Wilson</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Genome-wide demethylation destabilizes ctg.cag trinucleotide repeats in mammalian cells</article-title><source>Human Molecular Genetics</source><volume>13</volume><fpage>2979</fpage><lpage>2989</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddh317</pub-id><pub-id pub-id-type="pmid">15459182</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goula</surname> <given-names>AV</given-names></name><name><surname>Stys</surname> <given-names>A</given-names></name><name><surname>Chan</surname> <given-names>JP</given-names></name><name><surname>Trottier</surname> <given-names>Y</given-names></name><name><surname>Festenstein</surname> <given-names>R</given-names></name><name><surname>Merienne</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transcription elongation and tissue-specific somatic CAG instability</article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1003051</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003051</pub-id><pub-id pub-id-type="pmid">23209427</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname> <given-names>JS</given-names></name><name><surname>Haggarty</surname> <given-names>SJ</given-names></name><name><surname>Giacometti</surname> <given-names>E</given-names></name><name><surname>Dannenberg</surname> <given-names>JH</given-names></name><name><surname>Joseph</surname> <given-names>N</given-names></name><name><surname>Gao</surname> <given-names>J</given-names></name><name><surname>Nieland</surname> <given-names>TJ</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Mazitschek</surname> <given-names>R</given-names></name><name><surname>Bradner</surname> <given-names>JE</given-names></name><name><surname>DePinho</surname> <given-names>RA</given-names></name><name><surname>Jaenisch</surname> <given-names>R</given-names></name><name><surname>Tsai</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>HDAC2 negatively regulates memory formation and synaptic plasticity</article-title><source>Nature</source><volume>459</volume><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1038/nature07925</pub-id><pub-id pub-id-type="pmid">19424149</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harper</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders</article-title><source>Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences</source><volume>354</volume><fpage>957</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1098/rstb.1999.0446</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hockly</surname> <given-names>E</given-names></name><name><surname>Richon</surname> <given-names>VM</given-names></name><name><surname>Woodman</surname> <given-names>B</given-names></name><name><surname>Smith</surname> <given-names>DL</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Rosa</surname> <given-names>E</given-names></name><name><surname>Sathasivam</surname> <given-names>K</given-names></name><name><surname>Ghazi-Noori</surname> <given-names>S</given-names></name><name><surname>Mahal</surname> <given-names>A</given-names></name><name><surname>Lowden</surname> <given-names>PAS</given-names></name><name><surname>Steffan</surname> <given-names>JS</given-names></name><name><surname>Marsh</surname> <given-names>JL</given-names></name><name><surname>Thompson</surname> <given-names>LM</given-names></name><name><surname>Lewis</surname> <given-names>CM</given-names></name><name><surname>Marks</surname> <given-names>PA</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease</article-title><source>PNAS</source><volume>100</volume><fpage>2041</fpage><lpage>2046</lpage><pub-id pub-id-type="doi">10.1073/pnas.0437870100</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname> <given-names>I</given-names></name><name><surname>Thanh Lam</surname> <given-names>L</given-names></name><name><surname>Tomé</surname> <given-names>S</given-names></name><name><surname>Wansink</surname> <given-names>DG</given-names></name><name><surname>Te Riele</surname> <given-names>H</given-names></name><name><surname>Gourdon</surname> <given-names>G</given-names></name><name><surname>Morris</surname> <given-names>GE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The mouse mismatch repair protein, MSH3, is a nucleoplasmic protein that aggregates into denser nuclear bodies under conditions of stress</article-title><source>Journal of Cellular Biochemistry</source><volume>112</volume><fpage>1612</fpage><lpage>1621</lpage><pub-id pub-id-type="doi">10.1002/jcb.23075</pub-id><pub-id pub-id-type="pmid">21344488</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshino</surname> <given-names>M</given-names></name><name><surname>Tagawa</surname> <given-names>K</given-names></name><name><surname>Okuda</surname> <given-names>T</given-names></name><name><surname>Murata</surname> <given-names>M</given-names></name><name><surname>Oyanagi</surname> <given-names>K</given-names></name><name><surname>Arai</surname> <given-names>N</given-names></name><name><surname>Mizutani</surname> <given-names>T</given-names></name><name><surname>Kanazawa</surname> <given-names>I</given-names></name><name><surname>Wanker</surname> <given-names>EE</given-names></name><name><surname>Okazawa</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein</article-title><source>Journal of Neurochemistry</source><volume>87</volume><fpage>257</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01991.x</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>DW</given-names></name><name><surname>Sherman</surname> <given-names>BT</given-names></name><name><surname>Lempicki</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubert</surname> <given-names>L</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Dion</surname> <given-names>V</given-names></name><name><surname>Wilson</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Topoisomerase 1 and single-strand break repair modulate transcription-induced CAG repeat contraction in human cells</article-title><source>Molecular and Cellular Biology</source><volume>31</volume><fpage>3105</fpage><lpage>3112</lpage><pub-id pub-id-type="doi">10.1128/MCB.05158-11</pub-id><pub-id pub-id-type="pmid">21628532</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>H</given-names></name><name><surname>Pallos</surname> <given-names>J</given-names></name><name><surname>Jacques</surname> <given-names>V</given-names></name><name><surname>Lau</surname> <given-names>A</given-names></name><name><surname>Tang</surname> <given-names>B</given-names></name><name><surname>Cooper</surname> <given-names>A</given-names></name><name><surname>Syed</surname> <given-names>A</given-names></name><name><surname>Purcell</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Sharma</surname> <given-names>S</given-names></name><name><surname>Sangrey</surname> <given-names>GR</given-names></name><name><surname>Darnell</surname> <given-names>SB</given-names></name><name><surname>Plasterer</surname> <given-names>H</given-names></name><name><surname>Sadri-Vakili</surname> <given-names>G</given-names></name><name><surname>Gottesfeld</surname> <given-names>JM</given-names></name><name><surname>Thompson</surname> <given-names>LM</given-names></name><name><surname>Rusche</surname> <given-names>JR</given-names></name><name><surname>Marsh</surname> <given-names>JL</given-names></name><name><surname>Thomas</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease</article-title><source>Neurobiology of Disease</source><volume>46</volume><fpage>351</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2012.01.016</pub-id><pub-id pub-id-type="pmid">22590724</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>H</given-names></name><name><surname>Kast</surname> <given-names>RJ</given-names></name><name><surname>Steffan</surname> <given-names>JS</given-names></name><name><surname>Thomas</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>5280</fpage><lpage>5293</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds379</pub-id><pub-id pub-id-type="pmid">22965876</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Morris</surname> <given-names>CD</given-names></name><name><surname>Jacques</surname> <given-names>V</given-names></name><name><surname>Gottesfeld</surname> <given-names>JM</given-names></name><name><surname>Rusche</surname> <given-names>JR</given-names></name><name><surname>Thomas</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington's Disease Mice</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0152498</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0152498</pub-id><pub-id pub-id-type="pmid">27031333</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>L</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Salit</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name><name><surname>Oliver</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Synthetic spike-in standards for RNA-seq experiments</article-title><source>Genome Research</source><volume>21</volume><fpage>1543</fpage><lpage>1551</lpage><pub-id pub-id-type="doi">10.1101/gr.121095.111</pub-id><pub-id pub-id-type="pmid">21816910</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>J</given-names></name><name><surname>Bonini</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>CREB-binding protein modulates repeat instability in a <italic>Drosophila</italic> model for polyQ disease</article-title><source>Science</source><volume>315</volume><fpage>1857</fpage><lpage>1859</lpage><pub-id pub-id-type="doi">10.1126/science.1139517</pub-id><pub-id pub-id-type="pmid">17332375</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname> <given-names>RDW</given-names></name><name><surname>Chandru</surname> <given-names>A</given-names></name><name><surname>Watson</surname> <given-names>PJ</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Blades</surname> <given-names>M</given-names></name><name><surname>Robertson</surname> <given-names>NS</given-names></name><name><surname>Jamieson</surname> <given-names>AG</given-names></name><name><surname>Schwabe</surname> <given-names>JWR</given-names></name><name><surname>Cowley</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>14690</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-32927-9</pub-id><pub-id pub-id-type="pmid">30279482</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname> <given-names>RD</given-names></name><name><surname>Cowley</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts</article-title><source>Biochemical Society Transactions</source><volume>41</volume><fpage>741</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1042/BST20130010</pub-id><pub-id pub-id-type="pmid">23697933</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname> <given-names>L</given-names></name><name><surname>Evans</surname> <given-names>E</given-names></name><name><surname>Chen</surname> <given-names>CM</given-names></name><name><surname>Craven</surname> <given-names>L</given-names></name><name><surname>Detloff</surname> <given-names>PJ</given-names></name><name><surname>Ennis</surname> <given-names>M</given-names></name><name><surname>Shelbourne</surname> <given-names>PF</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis</article-title><source>Human Molecular Genetics</source><volume>12</volume><fpage>3359</fpage><lpage>3367</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddg352</pub-id><pub-id pub-id-type="pmid">14570710</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname> <given-names>L</given-names></name><name><surname>Shelbourne</surname> <given-names>PF</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?</article-title><source>Human Molecular Genetics</source><volume>9</volume><fpage>2539</fpage><lpage>2544</lpage><pub-id pub-id-type="doi">10.1093/hmg/9.17.2539</pub-id><pub-id pub-id-type="pmid">11030759</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Frank</surname> <given-names>CL</given-names></name><name><surname>Dobbin</surname> <given-names>MM</given-names></name><name><surname>Tsunemoto</surname> <given-names>RK</given-names></name><name><surname>Tu</surname> <given-names>W</given-names></name><name><surname>Peng</surname> <given-names>PL</given-names></name><name><surname>Guan</surname> <given-names>JS</given-names></name><name><surname>Lee</surname> <given-names>BH</given-names></name><name><surname>Moy</surname> <given-names>LY</given-names></name><name><surname>Giusti</surname> <given-names>P</given-names></name><name><surname>Broodie</surname> <given-names>N</given-names></name><name><surname>Mazitschek</surname> <given-names>R</given-names></name><name><surname>Delalle</surname> <given-names>I</given-names></name><name><surname>Haggarty</surname> <given-names>SJ</given-names></name><name><surname>Neve</surname> <given-names>RL</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Tsai</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity</article-title><source>Neuron</source><volume>60</volume><fpage>803</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.015</pub-id><pub-id pub-id-type="pmid">19081376</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knutson</surname> <given-names>SK</given-names></name><name><surname>Chyla</surname> <given-names>BJ</given-names></name><name><surname>Amann</surname> <given-names>JM</given-names></name><name><surname>Bhaskara</surname> <given-names>S</given-names></name><name><surname>Huppert</surname> <given-names>SS</given-names></name><name><surname>Hiebert</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks</article-title><source>The EMBO Journal</source><volume>27</volume><fpage>1017</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.51</pub-id><pub-id pub-id-type="pmid">18354499</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovalenko</surname> <given-names>M</given-names></name><name><surname>Dragileva</surname> <given-names>E</given-names></name><name><surname>St Claire</surname> <given-names>J</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>Guide</surname> <given-names>JR</given-names></name><name><surname>New</surname> <given-names>J</given-names></name><name><surname>Dong</surname> <given-names>H</given-names></name><name><surname>Kucherlapati</surname> <given-names>R</given-names></name><name><surname>Kucherlapati</surname> <given-names>MH</given-names></name><name><surname>Ehrlich</surname> <given-names>ME</given-names></name><name><surname>Lee</surname> <given-names>JM</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e44273</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0044273</pub-id><pub-id pub-id-type="pmid">22970194</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovtun</surname> <given-names>IV</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Bjoras</surname> <given-names>M</given-names></name><name><surname>Klungland</surname> <given-names>A</given-names></name><name><surname>Wilson</surname> <given-names>SH</given-names></name><name><surname>McMurray</surname> <given-names>CT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells</article-title><source>Nature</source><volume>447</volume><fpage>447</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1038/nature05778</pub-id><pub-id pub-id-type="pmid">17450122</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname> <given-names>P</given-names></name><name><surname>Cantle</surname> <given-names>JP</given-names></name><name><surname>Chatzopoulou</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>N</given-names></name><name><surname>Gao</surname> <given-names>F</given-names></name><name><surname>Al-Ramahi</surname> <given-names>I</given-names></name><name><surname>Lu</surname> <given-names>XH</given-names></name><name><surname>Ramos</surname> <given-names>EM</given-names></name><name><surname>El-Zein</surname> <given-names>K</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Deverasetty</surname> <given-names>S</given-names></name><name><surname>Tebbe</surname> <given-names>A</given-names></name><name><surname>Schaab</surname> <given-names>C</given-names></name><name><surname>Lavery</surname> <given-names>DJ</given-names></name><name><surname>Howland</surname> <given-names>D</given-names></name><name><surname>Kwak</surname> <given-names>S</given-names></name><name><surname>Botas</surname> <given-names>J</given-names></name><name><surname>Aaronson</surname> <given-names>JS</given-names></name><name><surname>Rosinski</surname> <given-names>J</given-names></name><name><surname>Coppola</surname> <given-names>G</given-names></name><name><surname>Horvath</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>XW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>623</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1038/nn.4256</pub-id><pub-id pub-id-type="pmid">26900923</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname> <given-names>E</given-names></name><name><surname>Fyfe</surname> <given-names>I</given-names></name><name><surname>Morton</surname> <given-names>AJ</given-names></name><name><surname>Monckton</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 huntington disease mice</article-title><source>Neurobiology of Disease</source><volume>76</volume><fpage>98</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2015.01.004</pub-id><pub-id pub-id-type="pmid">25662336</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JM</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Su</surname> <given-names>AI</given-names></name><name><surname>Walker</surname> <given-names>JR</given-names></name><name><surname>Wiltshire</surname> <given-names>T</given-names></name><name><surname>Kang</surname> <given-names>K</given-names></name><name><surname>Dragileva</surname> <given-names>E</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>Lopez</surname> <given-names>ET</given-names></name><name><surname>Boily</surname> <given-names>MJ</given-names></name><name><surname>Cyr</surname> <given-names>M</given-names></name><name><surname>Kohane</surname> <given-names>I</given-names></name><name><surname>Gusella</surname> <given-names>JF</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A novel approach to investigate tissue-specific trinucleotide repeat instability</article-title><source>BMC Systems Biology</source><volume>4</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1186/1752-0509-4-29</pub-id><pub-id pub-id-type="pmid">20302627</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JM</given-names></name><name><surname>Pinto</surname> <given-names>RM</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>St Claire</surname> <given-names>JC</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Quantification of age-dependent somatic CAG repeat instability in hdh CAG knock-in mice reveals different expansion dynamics in striatum and liver</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e23647</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0023647</pub-id><pub-id pub-id-type="pmid">21897851</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname> <given-names>JT</given-names></name><name><surname>Johnson</surname> <given-names>WE</given-names></name><name><surname>Parker</surname> <given-names>HS</given-names></name><name><surname>Jaffe</surname> <given-names>AE</given-names></name><name><surname>Storey</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The sva package for removing batch effects and other unwanted variation in high-throughput experiments</article-title><source>Bioinformatics</source><volume>28</volume><fpage>882</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts034</pub-id><pub-id pub-id-type="pmid">22257669</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Svaseq: removing batch effects and other unwanted noise from sequencing data</article-title><source>Nucleic Acids Research</source><volume>42</volume><elocation-id>e161</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gku864</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Handsaker</surname> <given-names>B</given-names></name><name><surname>Wysoker</surname> <given-names>A</given-names></name><name><surname>Fennell</surname> <given-names>T</given-names></name><name><surname>Ruan</surname> <given-names>J</given-names></name><name><surname>Homer</surname> <given-names>N</given-names></name><name><surname>Marth</surname> <given-names>G</given-names></name><name><surname>Abecasis</surname> <given-names>G</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name><collab>1000 Genome Project Data Processing Subgroup</collab></person-group><year iso-8601-date="2009">2009</year><article-title>The sequence alignment/Map format and SAMtools</article-title><source>Bioinformatics</source><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libby</surname> <given-names>RT</given-names></name><name><surname>Monckton</surname> <given-names>DG</given-names></name><name><surname>Fu</surname> <given-names>YH</given-names></name><name><surname>Martinez</surname> <given-names>RA</given-names></name><name><surname>McAbney</surname> <given-names>JP</given-names></name><name><surname>Lau</surname> <given-names>R</given-names></name><name><surname>Einum</surname> <given-names>DD</given-names></name><name><surname>Nichol</surname> <given-names>K</given-names></name><name><surname>Ware</surname> <given-names>CB</given-names></name><name><surname>Ptacek</surname> <given-names>LJ</given-names></name><name><surname>Pearson</surname> <given-names>CE</given-names></name><name><surname>La Spada</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Genomic context drives SCA7 CAG repeat instability, while expressed SCA7 cDNAs are intergenerationally and somatically stable in transgenic mice</article-title><source>Human Molecular Genetics</source><volume>12</volume><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddg006</pub-id><pub-id pub-id-type="pmid">12490531</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libby</surname> <given-names>RT</given-names></name><name><surname>Hagerman</surname> <given-names>KA</given-names></name><name><surname>Pineda</surname> <given-names>VV</given-names></name><name><surname>Lau</surname> <given-names>R</given-names></name><name><surname>Cho</surname> <given-names>DH</given-names></name><name><surname>Baccam</surname> <given-names>SL</given-names></name><name><surname>Axford</surname> <given-names>MM</given-names></name><name><surname>Cleary</surname> <given-names>JD</given-names></name><name><surname>Moore</surname> <given-names>JM</given-names></name><name><surname>Sopher</surname> <given-names>BL</given-names></name><name><surname>Tapscott</surname> <given-names>SJ</given-names></name><name><surname>Filippova</surname> <given-names>GN</given-names></name><name><surname>Pearson</surname> <given-names>CE</given-names></name><name><surname>La Spada</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>CTCF cis-regulates trinucleotide repeat instability in an epigenetic manner: a novel basis for mutational hot spot determination</article-title><source>PLOS Genetics</source><volume>4</volume><elocation-id>e1000257</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000257</pub-id><pub-id pub-id-type="pmid">19008940</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Wilson</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Transcription-induced CAG repeat contraction in human cells is mediated in part by transcription-coupled nucleotide excision repair</article-title><source>Molecular and Cellular Biology</source><volume>27</volume><fpage>6209</fpage><lpage>6217</lpage><pub-id pub-id-type="doi">10.1128/MCB.00739-07</pub-id><pub-id pub-id-type="pmid">17591697</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Wilson</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Diverse effects of individual mismatch repair components on transcription-induced CAG repeat instability in human cells</article-title><source>DNA Repair</source><volume>8</volume><fpage>878</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2009.04.024</pub-id><pub-id pub-id-type="pmid">19497791</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Wilson</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nucleotide excision repair, mismatch repair, and R-loops modulate convergent transcription-induced cell death and repeat instability</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e46807</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0046807</pub-id><pub-id pub-id-type="pmid">23056461</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloret</surname> <given-names>A</given-names></name><name><surname>Dragileva</surname> <given-names>E</given-names></name><name><surname>Teed</surname> <given-names>A</given-names></name><name><surname>Espinola</surname> <given-names>J</given-names></name><name><surname>Fossale</surname> <given-names>E</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>Lopez</surname> <given-names>E</given-names></name><name><surname>Myers</surname> <given-names>RH</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice</article-title><source>Human Molecular Genetics</source><volume>15</volume><fpage>2015</fpage><lpage>2024</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddl125</pub-id><pub-id pub-id-type="pmid">16687439</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Atalaya</surname> <given-names>JP</given-names></name><name><surname>Ito</surname> <given-names>S</given-names></name><name><surname>Valor</surname> <given-names>LM</given-names></name><name><surname>Benito</surname> <given-names>E</given-names></name><name><surname>Barco</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>8072</fpage><lpage>8084</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt590</pub-id><pub-id pub-id-type="pmid">23821663</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macdonald</surname> <given-names>M</given-names></name><name><surname>Ambrose</surname> <given-names>CM</given-names></name><name><surname>Duyao</surname> <given-names>MP</given-names></name><name><surname>Myers</surname> <given-names>RH</given-names></name><name><surname>Lin</surname> <given-names>C</given-names></name><name><surname>Srinidhi</surname> <given-names>L</given-names></name><name><surname>Barnes</surname> <given-names>G</given-names></name><name><surname>Taylor</surname> <given-names>SA</given-names></name><name><surname>James</surname> <given-names>M</given-names></name><name><surname>Groot</surname> <given-names>N</given-names></name><name><surname>MacFarlane</surname> <given-names>H</given-names></name><name><surname>Jenkins</surname> <given-names>B</given-names></name><name><surname>Anderson</surname> <given-names>MA</given-names></name><name><surname>Wexler</surname> <given-names>NS</given-names></name><name><surname>Gusella</surname> <given-names>JF</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name><name><surname>Baxendale</surname> <given-names>S</given-names></name><name><surname>Hummerich</surname> <given-names>H</given-names></name><name><surname>Kirby</surname> <given-names>S</given-names></name><name><surname>North</surname> <given-names>M</given-names></name><name><surname>Youngman</surname> <given-names>S</given-names></name><name><surname>Mott</surname> <given-names>R</given-names></name><name><surname>Zehetner</surname> <given-names>G</given-names></name><name><surname>Sedlacek</surname> <given-names>Z</given-names></name><name><surname>Poustka</surname> <given-names>A</given-names></name><name><surname>Frischauf</surname> <given-names>AM</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name><name><surname>Buckler</surname> <given-names>AJ</given-names></name><name><surname>Church</surname> <given-names>D</given-names></name><name><surname>Doucette-Stamm</surname> <given-names>L</given-names></name><name><surname>O'Donovan</surname> <given-names>MC</given-names></name><name><surname>Riba-Ramirez</surname> <given-names>L</given-names></name><name><surname>Shah</surname> <given-names>M</given-names></name><name><surname>Stanton</surname> <given-names>VP</given-names></name><name><surname>Strobel</surname> <given-names>SA</given-names></name><name><surname>Draths</surname> <given-names>KM</given-names></name><name><surname>Wales</surname> <given-names>JL</given-names></name><name><surname>Dervan</surname> <given-names>P</given-names></name><name><surname>Housman</surname> <given-names>DE</given-names></name><name><surname>Altherr</surname> <given-names>M</given-names></name><name><surname>Shiang</surname> <given-names>R</given-names></name><name><surname>Thompson</surname> <given-names>L</given-names></name><name><surname>Fielder</surname> <given-names>T</given-names></name><name><surname>Wasmuth</surname> <given-names>JJ</given-names></name><name><surname>Tagle</surname> <given-names>D</given-names></name><name><surname>Valdes</surname> <given-names>J</given-names></name><name><surname>Elmer</surname> <given-names>L</given-names></name><name><surname>Allard</surname> <given-names>M</given-names></name><name><surname>Castilla</surname> <given-names>L</given-names></name><name><surname>Swaroop</surname> <given-names>M</given-names></name><name><surname>Blanchard</surname> <given-names>K</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Snell</surname> <given-names>R</given-names></name><name><surname>Holloway</surname> <given-names>T</given-names></name><name><surname>Gillespie</surname> <given-names>K</given-names></name><name><surname>Datson</surname> <given-names>N</given-names></name><name><surname>Shaw</surname> <given-names>D</given-names></name><name><surname>Harper</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes</article-title><source>Cell</source><volume>72</volume><fpage>971</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90585-E</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuown</surname> <given-names>SC</given-names></name><name><surname>Barrett</surname> <given-names>RM</given-names></name><name><surname>Matheos</surname> <given-names>DP</given-names></name><name><surname>Post</surname> <given-names>RJ</given-names></name><name><surname>Rogge</surname> <given-names>GA</given-names></name><name><surname>Alenghat</surname> <given-names>T</given-names></name><name><surname>Mullican</surname> <given-names>SE</given-names></name><name><surname>Jones</surname> <given-names>S</given-names></name><name><surname>Rusche</surname> <given-names>JR</given-names></name><name><surname>Lazar</surname> <given-names>MA</given-names></name><name><surname>Wood</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>HDAC3 is a critical negative regulator of Long-Term memory formation</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>764</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5052-10.2011</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mielcarek</surname> <given-names>M</given-names></name><name><surname>Benn</surname> <given-names>CL</given-names></name><name><surname>Franklin</surname> <given-names>SA</given-names></name><name><surname>Smith</surname> <given-names>DL</given-names></name><name><surname>Woodman</surname> <given-names>B</given-names></name><name><surname>Marks</surname> <given-names>PA</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e27746</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0027746</pub-id><pub-id pub-id-type="pmid">22140466</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mielcarek</surname> <given-names>M</given-names></name><name><surname>Landles</surname> <given-names>C</given-names></name><name><surname>Weiss</surname> <given-names>A</given-names></name><name><surname>Bradaia</surname> <given-names>A</given-names></name><name><surname>Seredenina</surname> <given-names>T</given-names></name><name><surname>Inuabasi</surname> <given-names>L</given-names></name><name><surname>Osborne</surname> <given-names>GF</given-names></name><name><surname>Wadel</surname> <given-names>K</given-names></name><name><surname>Touller</surname> <given-names>C</given-names></name><name><surname>Butler</surname> <given-names>R</given-names></name><name><surname>Robertson</surname> <given-names>J</given-names></name><name><surname>Franklin</surname> <given-names>SA</given-names></name><name><surname>Smith</surname> <given-names>DL</given-names></name><name><surname>Park</surname> <given-names>L</given-names></name><name><surname>Marks</surname> <given-names>PA</given-names></name><name><surname>Wanker</surname> <given-names>EE</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name><name><surname>Luthi-Carter</surname> <given-names>R</given-names></name><name><surname>van der Putten</surname> <given-names>H</given-names></name><name><surname>Beaumont</surname> <given-names>V</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration</article-title><source>PLOS Biology</source><volume>11</volume><elocation-id>e1001717</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001717</pub-id><pub-id pub-id-type="pmid">24302884</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>KM</given-names></name><name><surname>Tjeertes</surname> <given-names>JV</given-names></name><name><surname>Coates</surname> <given-names>J</given-names></name><name><surname>Legube</surname> <given-names>G</given-names></name><name><surname>Polo</surname> <given-names>SE</given-names></name><name><surname>Britton</surname> <given-names>S</given-names></name><name><surname>Jackson</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>17</volume><fpage>1144</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1899</pub-id><pub-id pub-id-type="pmid">20802485</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>CJ</given-names></name><name><surname>Kim</surname> <given-names>GY</given-names></name><name><surname>Zhao</surname> <given-names>X</given-names></name><name><surname>Usdin</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>All three mammalian MutL complexes are required for repeat expansion in a mouse cell model of the fragile X-related disorders</article-title><source>PLOS Genetics</source><volume>16</volume><elocation-id>e1008902</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008902</pub-id><pub-id pub-id-type="pmid">32589669</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollersen</surname> <given-names>L</given-names></name><name><surname>Rowe</surname> <given-names>AD</given-names></name><name><surname>Illuzzi</surname> <given-names>JL</given-names></name><name><surname>Hildrestrand</surname> <given-names>GA</given-names></name><name><surname>Gerhold</surname> <given-names>KJ</given-names></name><name><surname>Tveteras</surname> <given-names>L</given-names></name><name><surname>Bjolgerud</surname> <given-names>A</given-names></name><name><surname>Wilson</surname> <given-names>DM</given-names></name><name><surname>Bjoras</surname> <given-names>M</given-names></name><name><surname>Klungland</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>4939</fpage><lpage>4947</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds337</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname> <given-names>RL</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Potthoff</surname> <given-names>MJ</given-names></name><name><surname>Haberland</surname> <given-names>M</given-names></name><name><surname>Fielitz</surname> <given-names>J</given-names></name><name><surname>Qi</surname> <given-names>X</given-names></name><name><surname>Hill</surname> <given-names>JA</given-names></name><name><surname>Richardson</surname> <given-names>JA</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility</article-title><source>Genes &amp; Development</source><volume>21</volume><fpage>1790</fpage><lpage>1802</lpage><pub-id pub-id-type="doi">10.1101/gad.1563807</pub-id><pub-id pub-id-type="pmid">17639084</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname> <given-names>RL</given-names></name><name><surname>Potthoff</surname> <given-names>MJ</given-names></name><name><surname>Haberland</surname> <given-names>M</given-names></name><name><surname>Qi</surname> <given-names>X</given-names></name><name><surname>Matsuzaki</surname> <given-names>S</given-names></name><name><surname>Humphries</surname> <given-names>KM</given-names></name><name><surname>Richardson</surname> <given-names>JA</given-names></name><name><surname>Bassel-Duby</surname> <given-names>R</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice</article-title><source>Journal of Clinical Investigation</source><volume>118</volume><fpage>3588</fpage><lpage>3597</lpage><pub-id pub-id-type="doi">10.1172/JCI35847</pub-id><pub-id pub-id-type="pmid">18830415</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moumné</surname> <given-names>L</given-names></name><name><surname>Campbell</surname> <given-names>K</given-names></name><name><surname>Howland</surname> <given-names>D</given-names></name><name><surname>Ouyang</surname> <given-names>Y</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's disease</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e31080</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0031080</pub-id><pub-id pub-id-type="pmid">22347433</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouro Pinto</surname> <given-names>R</given-names></name><name><surname>Arning</surname> <given-names>L</given-names></name><name><surname>Giordano</surname> <given-names>JV</given-names></name><name><surname>Razghandi</surname> <given-names>P</given-names></name><name><surname>Andrew</surname> <given-names>MA</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>Correia</surname> <given-names>K</given-names></name><name><surname>Mysore</surname> <given-names>JS</given-names></name><name><surname>Grote Urtubey</surname> <given-names>DM</given-names></name><name><surname>Parwez</surname> <given-names>CR</given-names></name><name><surname>von Hein</surname> <given-names>SM</given-names></name><name><surname>Clark</surname> <given-names>HB</given-names></name><name><surname>Nguyen</surname> <given-names>HP</given-names></name><name><surname>Förster</surname> <given-names>E</given-names></name><name><surname>Beller</surname> <given-names>A</given-names></name><name><surname>Jayadaev</surname> <given-names>S</given-names></name><name><surname>Keene</surname> <given-names>CD</given-names></name><name><surname>Bird</surname> <given-names>TD</given-names></name><name><surname>Lucente</surname> <given-names>D</given-names></name><name><surname>Vonsattel</surname> <given-names>JP</given-names></name><name><surname>Orr</surname> <given-names>H</given-names></name><name><surname>Saft</surname> <given-names>C</given-names></name><name><surname>Petrasch-Parwez</surname> <given-names>E</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Patterns of CAG repeat instability in the central nervous system and periphery in Huntington's disease and in spinocerebellar ataxia type 1</article-title><source>Human Molecular Genetics</source><volume>29</volume><fpage>2551</fpage><lpage>2567</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddaa139</pub-id><pub-id pub-id-type="pmid">32761094</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestor</surname> <given-names>CE</given-names></name><name><surname>Monckton</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Correlation of inter-locus polyglutamine toxicity with CAG•CTG triplet repeat expandability and flanking genomic DNA GC content</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e28260</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0028260</pub-id><pub-id pub-id-type="pmid">22163004</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neto</surname> <given-names>JL</given-names></name><name><surname>Lee</surname> <given-names>JM</given-names></name><name><surname>Afridi</surname> <given-names>A</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>Guide</surname> <given-names>JR</given-names></name><name><surname>Dempsey</surname> <given-names>S</given-names></name><name><surname>Lager</surname> <given-names>B</given-names></name><name><surname>Alonso</surname> <given-names>I</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name><name><surname>Pinto</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic contributors to intergenerational CAG repeat instability in Huntington's Disease Knock-In Mice</article-title><source>Genetics</source><volume>205</volume><fpage>503</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1534/genetics.116.195578</pub-id><pub-id pub-id-type="pmid">27913616</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piekna-Przybylska</surname> <given-names>D</given-names></name><name><surname>Bambara</surname> <given-names>RA</given-names></name><name><surname>Balakrishnan</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Acetylation regulates DNA repair mechanisms in human cells</article-title><source>Cell Cycle</source><volume>15</volume><fpage>1506</fpage><lpage>1517</lpage><pub-id pub-id-type="doi">10.1080/15384101.2016.1176815</pub-id><pub-id pub-id-type="pmid">27104361</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname> <given-names>RM</given-names></name><name><surname>Dragileva</surname> <given-names>E</given-names></name><name><surname>Kirby</surname> <given-names>A</given-names></name><name><surname>Lloret</surname> <given-names>A</given-names></name><name><surname>Lopez</surname> <given-names>E</given-names></name><name><surname>St. Claire</surname> <given-names>J</given-names></name><name><surname>Panigrahi</surname> <given-names>GB</given-names></name><name><surname>Hou</surname> <given-names>C</given-names></name><name><surname>Holloway</surname> <given-names>K</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>Guide</surname> <given-names>JR</given-names></name><name><surname>Cohen</surname> <given-names>PE</given-names></name><name><surname>Li</surname> <given-names>G-M</given-names></name><name><surname>Pearson</surname> <given-names>CE</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's Disease Mice: Genome-Wide and Candidate Approaches</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003930</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003930</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinti</surname> <given-names>L</given-names></name><name><surname>Chopra</surname> <given-names>V</given-names></name><name><surname>Rotili</surname> <given-names>D</given-names></name><name><surname>Valente</surname> <given-names>S</given-names></name><name><surname>Amore</surname> <given-names>A</given-names></name><name><surname>Franci</surname> <given-names>G</given-names></name><name><surname>Meade</surname> <given-names>S</given-names></name><name><surname>Valenza</surname> <given-names>M</given-names></name><name><surname>Altucci</surname> <given-names>L</given-names></name><name><surname>Maxwell</surname> <given-names>MM</given-names></name><name><surname>Cattaneo</surname> <given-names>E</given-names></name><name><surname>Hersch</surname> <given-names>S</given-names></name><name><surname>Mai</surname> <given-names>A</given-names></name><name><surname>Kazantsev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Evaluation of histone deacetylases as drug targets in Huntington's disease models Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model</article-title><source>PLOS Currents</source><volume>2</volume><elocation-id>RRN1172</elocation-id><pub-id pub-id-type="doi">10.1371/currents.RRN1172</pub-id><pub-id pub-id-type="pmid">20877454</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radhakrishnan</surname> <given-names>R</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Yuan</surname> <given-names>F</given-names></name><name><surname>Yuan</surname> <given-names>Z</given-names></name><name><surname>Telles</surname> <given-names>E</given-names></name><name><surname>Fang</surname> <given-names>J</given-names></name><name><surname>Coppola</surname> <given-names>D</given-names></name><name><surname>Shibata</surname> <given-names>D</given-names></name><name><surname>Lane</surname> <given-names>WS</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Seto</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2</article-title><source>Journal of Biological Chemistry</source><volume>290</volume><fpage>22795</fpage><lpage>22804</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.612945</pub-id><pub-id pub-id-type="pmid">26221039</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>MD</given-names></name><name><surname>McCarthy</surname> <given-names>DJ</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>edgeR: a bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathasivam</surname> <given-names>K</given-names></name><name><surname>Neueder</surname> <given-names>A</given-names></name><name><surname>Gipson</surname> <given-names>TA</given-names></name><name><surname>Landles</surname> <given-names>C</given-names></name><name><surname>Benjamin</surname> <given-names>AC</given-names></name><name><surname>Bondulich</surname> <given-names>MK</given-names></name><name><surname>Smith</surname> <given-names>DL</given-names></name><name><surname>Faull</surname> <given-names>RL</given-names></name><name><surname>Roos</surname> <given-names>RA</given-names></name><name><surname>Howland</surname> <given-names>D</given-names></name><name><surname>Detloff</surname> <given-names>PJ</given-names></name><name><surname>Housman</surname> <given-names>DE</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease</article-title><source>PNAS</source><volume>110</volume><fpage>2366</fpage><lpage>2370</lpage><pub-id pub-id-type="doi">10.1073/pnas.1221891110</pub-id><pub-id pub-id-type="pmid">23341618</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>S</given-names></name><name><surname>Taliyan</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transcriptional dysregulation in Huntington's disease: The role of histone deacetylases</article-title><source>Pharmacological Research</source><volume>100</volume><fpage>157</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2015.08.002</pub-id><pub-id pub-id-type="pmid">26254871</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siebzehnrübl</surname> <given-names>FA</given-names></name><name><surname>Raber</surname> <given-names>KA</given-names></name><name><surname>Urbach</surname> <given-names>YK</given-names></name><name><surname>Schulze-Krebs</surname> <given-names>A</given-names></name><name><surname>Canneva</surname> <given-names>F</given-names></name><name><surname>Moceri</surname> <given-names>S</given-names></name><name><surname>Habermeyer</surname> <given-names>J</given-names></name><name><surname>Achoui</surname> <given-names>D</given-names></name><name><surname>Gupta</surname> <given-names>B</given-names></name><name><surname>Steindler</surname> <given-names>DA</given-names></name><name><surname>Stephan</surname> <given-names>M</given-names></name><name><surname>Nguyen</surname> <given-names>HP</given-names></name><name><surname>Bonin</surname> <given-names>M</given-names></name><name><surname>Riess</surname> <given-names>O</given-names></name><name><surname>Bauer</surname> <given-names>A</given-names></name><name><surname>Aigner</surname> <given-names>L</given-names></name><name><surname>Couillard-Despres</surname> <given-names>S</given-names></name><name><surname>Paucar</surname> <given-names>MA</given-names></name><name><surname>Svenningsson</surname> <given-names>P</given-names></name><name><surname>Osmand</surname> <given-names>A</given-names></name><name><surname>Andreew</surname> <given-names>A</given-names></name><name><surname>Zabel</surname> <given-names>C</given-names></name><name><surname>Weiss</surname> <given-names>A</given-names></name><name><surname>Kuhn</surname> <given-names>R</given-names></name><name><surname>Moussaoui</surname> <given-names>S</given-names></name><name><surname>Blockx</surname> <given-names>I</given-names></name><name><surname>Van der Linden</surname> <given-names>A</given-names></name><name><surname>Cheong</surname> <given-names>RY</given-names></name><name><surname>Roybon</surname> <given-names>L</given-names></name><name><surname>Petersén</surname> <given-names>Å</given-names></name><name><surname>von Hörsten</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition</article-title><source>PNAS</source><volume>115</volume><fpage>E8765</fpage><lpage>E8774</lpage><pub-id pub-id-type="doi">10.1073/pnas.1807962115</pub-id><pub-id pub-id-type="pmid">30150378</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suelves</surname> <given-names>N</given-names></name><name><surname>Kirkham-McCarthy</surname> <given-names>L</given-names></name><name><surname>Lahue</surname> <given-names>RS</given-names></name><name><surname>Ginés</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>6082</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-05125-2</pub-id><pub-id pub-id-type="pmid">28729730</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swami</surname> <given-names>M</given-names></name><name><surname>Hendricks</surname> <given-names>AE</given-names></name><name><surname>Gillis</surname> <given-names>T</given-names></name><name><surname>Massood</surname> <given-names>T</given-names></name><name><surname>Mysore</surname> <given-names>J</given-names></name><name><surname>Myers</surname> <given-names>RH</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>3039</fpage><lpage>3047</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp242</pub-id><pub-id pub-id-type="pmid">19465745</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>EA</given-names></name><name><surname>Coppola</surname> <given-names>G</given-names></name><name><surname>Desplats</surname> <given-names>PA</given-names></name><name><surname>Tang</surname> <given-names>B</given-names></name><name><surname>Soragni</surname> <given-names>E</given-names></name><name><surname>Burnett</surname> <given-names>R</given-names></name><name><surname>Gao</surname> <given-names>F</given-names></name><name><surname>Fitzgerald</surname> <given-names>KM</given-names></name><name><surname>Borok</surname> <given-names>JF</given-names></name><name><surname>Herman</surname> <given-names>D</given-names></name><name><surname>Geschwind</surname> <given-names>DH</given-names></name><name><surname>Gottesfeld</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice</article-title><source>PNAS</source><volume>105</volume><fpage>15564</fpage><lpage>15569</lpage><pub-id pub-id-type="doi">10.1073/pnas.0804249105</pub-id><pub-id pub-id-type="pmid">18829438</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomé</surname> <given-names>S</given-names></name><name><surname>Manley</surname> <given-names>K</given-names></name><name><surname>Simard</surname> <given-names>JP</given-names></name><name><surname>Clark</surname> <given-names>GW</given-names></name><name><surname>Slean</surname> <given-names>MM</given-names></name><name><surname>Swami</surname> <given-names>M</given-names></name><name><surname>Shelbourne</surname> <given-names>PF</given-names></name><name><surname>Tillier</surname> <given-names>ER</given-names></name><name><surname>Monckton</surname> <given-names>DG</given-names></name><name><surname>Messer</surname> <given-names>A</given-names></name><name><surname>Pearson</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003280</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003280</pub-id><pub-id pub-id-type="pmid">23468640</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trivedi</surname> <given-names>CM</given-names></name><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>Yin</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Zhu</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Floss</surname> <given-names>T</given-names></name><name><surname>Goettlicher</surname> <given-names>M</given-names></name><name><surname>Noppinger</surname> <given-names>PR</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Ferrari</surname> <given-names>VA</given-names></name><name><surname>Abrams</surname> <given-names>CS</given-names></name><name><surname>Gruber</surname> <given-names>PJ</given-names></name><name><surname>Epstein</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity</article-title><source>Nature Medicine</source><volume>13</volume><fpage>324</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1038/nm1552</pub-id><pub-id pub-id-type="pmid">17322895</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veitch</surname> <given-names>NJ</given-names></name><name><surname>Ennis</surname> <given-names>M</given-names></name><name><surname>McAbney</surname> <given-names>JP</given-names></name><name><surname>Shelbourne</surname> <given-names>PF</given-names></name><name><surname>Monckton</surname> <given-names>DG</given-names></name><collab>US-Venezuela Collaborative Research Project</collab></person-group><year iso-8601-date="2007">2007</year><article-title>Inherited cag.ctg allele length is a major modifier of somatic mutation length variability in Huntington disease</article-title><source>DNA Repair</source><volume>6</volume><fpage>789</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2007.01.002</pub-id><pub-id pub-id-type="pmid">17293170</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkatraman</surname> <given-names>A</given-names></name><name><surname>Hu</surname> <given-names>YS</given-names></name><name><surname>Didonna</surname> <given-names>A</given-names></name><name><surname>Cvetanovic</surname> <given-names>M</given-names></name><name><surname>Krbanjevic</surname> <given-names>A</given-names></name><name><surname>Bilesimo</surname> <given-names>P</given-names></name><name><surname>Opal</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The histone deacetylase HDAC3 is essential for purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1</article-title><source>Human Molecular Genetics</source><volume>23</volume><fpage>3733</fpage><lpage>3745</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu081</pub-id><pub-id pub-id-type="pmid">24594842</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vonsattel</surname> <given-names>JP</given-names></name><name><surname>Myers</surname> <given-names>RH</given-names></name><name><surname>Stevens</surname> <given-names>TJ</given-names></name><name><surname>Ferrante</surname> <given-names>RJ</given-names></name><name><surname>Bird</surname> <given-names>ED</given-names></name><name><surname>Richardson</surname> <given-names>EP</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Neuropathological classification of Huntington's disease</article-title><source>Journal of Neuropathology and Experimental Neurology</source><volume>44</volume><fpage>559</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1097/00005072-198511000-00003</pub-id><pub-id pub-id-type="pmid">2932539</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>RSeQC: quality control of RNA-seq experiments</article-title><source>Bioinformatics</source><volume>28</volume><fpage>2184</fpage><lpage>2185</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts356</pub-id><pub-id pub-id-type="pmid">22743226</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname> <given-names>VC</given-names></name><name><surname>Auerbach</surname> <given-names>W</given-names></name><name><surname>White</surname> <given-names>JK</given-names></name><name><surname>Srinidhi</surname> <given-names>J</given-names></name><name><surname>Auerbach</surname> <given-names>A</given-names></name><name><surname>Ryan</surname> <given-names>A</given-names></name><name><surname>Duyao</surname> <given-names>MP</given-names></name><name><surname>Vrbanac</surname> <given-names>V</given-names></name><name><surname>Weaver</surname> <given-names>M</given-names></name><name><surname>Gusella</surname> <given-names>JF</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse</article-title><source>Human Molecular Genetics</source><volume>8</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1093/hmg/8.1.115</pub-id><pub-id pub-id-type="pmid">9887339</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname> <given-names>VC</given-names></name><name><surname>White</surname> <given-names>JK</given-names></name><name><surname>Gutekunst</surname> <given-names>CA</given-names></name><name><surname>Vrbanac</surname> <given-names>V</given-names></name><name><surname>Weaver</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>XJ</given-names></name><name><surname>Li</surname> <given-names>SH</given-names></name><name><surname>Yi</surname> <given-names>H</given-names></name><name><surname>Vonsattel</surname> <given-names>JP</given-names></name><name><surname>Gusella</surname> <given-names>JF</given-names></name><name><surname>Hersch</surname> <given-names>S</given-names></name><name><surname>Auerbach</surname> <given-names>W</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice</article-title><source>Human Molecular Genetics</source><volume>9</volume><fpage>503</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1093/hmg/9.4.503</pub-id><pub-id pub-id-type="pmid">10699173</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname> <given-names>VC</given-names></name><name><surname>Gutekunst</surname> <given-names>CA</given-names></name><name><surname>Vrbanac</surname> <given-names>V</given-names></name><name><surname>Lebel</surname> <given-names>LA</given-names></name><name><surname>Schilling</surname> <given-names>G</given-names></name><name><surname>Hersch</surname> <given-names>S</given-names></name><name><surname>Friedlander</surname> <given-names>RM</given-names></name><name><surname>Gusella</surname> <given-names>JF</given-names></name><name><surname>Vonsattel</surname> <given-names>JP</given-names></name><name><surname>Borchelt</surname> <given-names>DR</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in hdh CAG knock-in mice</article-title><source>Human Molecular Genetics</source><volume>11</volume><fpage>633</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1093/hmg/11.6.633</pub-id><pub-id pub-id-type="pmid">11912178</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname> <given-names>VC</given-names></name><name><surname>Lebel</surname> <given-names>LA</given-names></name><name><surname>Vrbanac</surname> <given-names>V</given-names></name><name><surname>Teed</surname> <given-names>A</given-names></name><name><surname>te Riele</surname> <given-names>H</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mismatch repair gene Msh2 modifies the timing of early disease in hdh(Q111) striatum</article-title><source>Human Molecular Genetics</source><volume>12</volume><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddg056</pub-id><pub-id pub-id-type="pmid">12554681</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>JK</given-names></name><name><surname>Auerbach</surname> <given-names>W</given-names></name><name><surname>Duyao</surname> <given-names>MP</given-names></name><name><surname>Vonsattel</surname> <given-names>JP</given-names></name><name><surname>Gusella</surname> <given-names>JF</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name><name><surname>MacDonald</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion</article-title><source>Nature Genetics</source><volume>17</volume><fpage>404</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/ng1297-404</pub-id><pub-id pub-id-type="pmid">9398841</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>GM</given-names></name><name><surname>Paschalis</surname> <given-names>V</given-names></name><name><surname>Ortega</surname> <given-names>J</given-names></name><name><surname>Muskett</surname> <given-names>FW</given-names></name><name><surname>Hodgkinson</surname> <given-names>JT</given-names></name><name><surname>Li</surname> <given-names>GM</given-names></name><name><surname>Schwabe</surname> <given-names>JWR</given-names></name><name><surname>Lahue</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>HDAC3 deacetylates the DNA mismatch repair factor MutSβ to stimulate triplet repeat expansions</article-title><source>PNAS</source><volume>117</volume><fpage>23597</fpage><lpage>23605</lpage><pub-id pub-id-type="doi">10.1073/pnas.2013223117</pub-id><pub-id pub-id-type="pmid">32900932</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>TD</given-names></name><name><surname>Nacu</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>And SNP-tolerant detection of complex variants and splicing in short reads</article-title><source>Bioinformatics</source><volume>26</volume><fpage>873</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq057</pub-id><pub-id pub-id-type="pmid">20147302</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>JH</given-names></name><name><surname>Freudenreich</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The Rtt109 histone acetyltransferase facilitates error-free replication to prevent CAG/CTG repeat contractions</article-title><source>DNA Repair</source><volume>9</volume><fpage>414</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2009.12.022</pub-id><pub-id pub-id-type="pmid">20083442</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Joo</surname> <given-names>HY</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Williams</surname> <given-names>KA</given-names></name><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Hu</surname> <given-names>C</given-names></name><name><surname>Tong</surname> <given-names>D</given-names></name><name><surname>Haakenson</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Pavlovicz</surname> <given-names>RE</given-names></name><name><surname>Jones</surname> <given-names>A</given-names></name><name><surname>Schmidt</surname> <given-names>KH</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Dong</surname> <given-names>H</given-names></name><name><surname>Shan</surname> <given-names>B</given-names></name><name><surname>Fang</surname> <given-names>B</given-names></name><name><surname>Radhakrishnan</surname> <given-names>R</given-names></name><name><surname>Glazer</surname> <given-names>PM</given-names></name><name><surname>Matthias</surname> <given-names>P</given-names></name><name><surname>Koomen</surname> <given-names>J</given-names></name><name><surname>Seto</surname> <given-names>E</given-names></name><name><surname>Bepler</surname> <given-names>G</given-names></name><name><surname>Nicosia</surname> <given-names>SV</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Gu</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>GM</given-names></name><name><surname>Bai</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSα</article-title><source>Molecular Cell</source><volume>55</volume><fpage>31</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.04.028</pub-id><pub-id pub-id-type="pmid">24882211</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Hu</surname> <given-names>C</given-names></name><name><surname>Moses</surname> <given-names>N</given-names></name><name><surname>Haakenson</surname> <given-names>J</given-names></name><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Quan</surname> <given-names>D</given-names></name><name><surname>Fang</surname> <given-names>B</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name><name><surname>Bai</surname> <given-names>W</given-names></name><name><surname>Bepler</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>GM</given-names></name><name><surname>Zhang</surname> <given-names>XM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>HDAC6 regulates DNA damage response via deacetylating MLH1</article-title><source>Journal of Biological Chemistry</source><volume>294</volume><fpage>5813</fpage><lpage>5826</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.006374</pub-id><pub-id pub-id-type="pmid">30770470</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>XN</given-names></name><name><surname>Usdin</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>FAN1 protects against repeat expansions in a fragile X mouse model</article-title><source>DNA Repair</source><volume>69</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2018.07.001</pub-id><pub-id pub-id-type="pmid">29990673</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.55911.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Orr</surname><given-names>Harry T</given-names></name><role>Reviewing Editor</role><aff><institution>University of Minnesota</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Southwell</surname><given-names>Amber L</given-names></name><role>Reviewer</role><aff><institution>University of Central Florida</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This manuscript provides novel data that histone deacetytlase 2, HDAC2, impacts transcriptional dysregulation found in striatal medium-spiny neurons affected with Huntington's disease. Loss of HDAC2 function is shown to normalize a subset of transcriptionally dysregulated genes associated with HD.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your manuscript &quot;Molecular and cellular consequences of genetic knockout of <italic>Hdac2</italic> and <italic>Hdac3</italic> in striatal medium spiny neurons of Huntington's disease knockin mice&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by K VijayRaghavan as the Senior Editor. The reviewers and the Reviewing Editor drafted this decision letter to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>This manuscript provides novel data that histone deacetytlase 2, HDAC2, impacts transcriptional dysregulation found in striatal medium-spiny neurons affected with Huntington's disease. Loss of HDAC2 function is shown to normalize a subset of transcriptionally dysregulated genes associated with HD.</p><p>Essential Revisions:</p><p>1) The submitted version is directed at the assessing the ability of <italic>Hdac2</italic> and <italic>Hdac3</italic> deletion to modify both cellular and molecular phenotypes associated with HD. As the authors note, the data hint the <italic>Hdac2</italic> deletion modifies HD phenotypes via mechanisms unrelated to CAG expansion. The inability of the data to firmly interpret the relationship between instability and striatal phenotypes detracts from the impact of the current version. All reviewers found the most compelling data to be the impact of HADC loss-of-function on alterations in gene expression associated with HD. Thus, it is critical that the manuscript be revised to focus on HDAC and medium-spiny neuron transcriptional regulation. Perhaps the effect of HADCs on somatic instability would best be presented not as the lead but as a possible mechanism by which dysregulated genes associated with HD are normalized. Likewise, the title should be reconfigured to reflect focus on HDACs and MSN transcriptional dysregulation in HD.</p><p>2) There is a lack of mechanism provided for the observed molecular changes. The Manuscript proposes a potential mechanism for how HDACs may be contributing to stability by modifying chromatin but do not provide evidence to support this. It is alternatively suggested that KO could affect acetylation of repair proteins. The data presented does not really support this proposed mechanism as there is no change in expression of DDR genes at transcript level and one (MSH3) at the protein level. It would have been helpful to assess levels of unmodified or acetylated MSH2 or MLH1 in the manuscript as these are known modifiers of somatic instability and were suggested in the Discussion. There is a description of an antibody for detecting MSH2 on western blots in the Materials and methods, however this data does not appear in the manuscript nor in the supplement. This could support data on potential mechanisms. Therefore it is recommended to revise the manuscript overall to prioritize the transcriptional normalization that occurs from KD and focus on those molecular insights with reduced focus on the somatic repeat instability piece. At present there is not a direct mechanism on somatic repeat instability and <italic>Hdac2</italic> KD and data provided for this possibility in the manuscript would suggest this may not be the case (no changes in DDR genes or levels of MSH3 protein).</p><p>3) The methodology regarding how the mice colonies were made and maintained is confusing. Are these mice heterozygous or homozygous for Q111? Perhaps a supplemental breeding scheme diagram? This is vital for data interpretation. Also, please include the Q111 genotype in the main text as well as in the Materials and methods.</p><p>4) Presentation of RNAseq data is difficult to follow and not fully described. For instance, it is not clear from the text whether genes that are consistently altered in HD are restored in expression and information on statistical enrichment. Similarly, the comparison with Langfelder et al., data is unclear. Suggest to use graphical visuals representing gene changes and observed overlaps instead of tables or guide readers' eye to specific rows and columns being discussed when referencing figures. Further, suggest adding additional figure references in the fourth paragraph of the subsection “Impact of MSN-specific <italic>Hdac2</italic> knockout on the transcriptome” for RNAseq comparisons to make it more clear so to which datasets text is referring to. Finally, conclusions relating to analysis from RNAseq does not appear to be consistent with the data. While the manuscript states that none of the rescued genes met the adjusted p-value cut-off (subsection “A subset of genes dysregulated in <italic>Htt</italic><sup>Q111</sup> striata is reversed by knockout of <italic>Hdac2</italic> in MSNs”), the author's interpretation of results suggests a rescue effect (subsection “A subset of genes dysregulated in <italic>Htt</italic><sup>Q111</sup> striata is reversed by knockout of <italic>Hdac2</italic> in MSNs”, last paragraph). Due to the lack of significance, would recommend re-phrasing to a suggested rescue rather than a definite one.</p><p>5) While the Discussion addresses some of the previous studies investigating HDACs and HDAC inhibitors in HD, this is by no means comprehensive. Studies by Hoshino et al., 2003, and Qunti et al., 2010, should be included discussing HDAC expression in HD human and mouse tissue, respectively. Additionally, work by Jia et al., 2016, Chopra et al., 2016, and Siebzehnrubl et al., 2018, discuss the effects of various HDAC inhibitors on models of HD. Please include these in your Discussion section and also give a brief introduction to this previous work in the Introduction.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.55911.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>1) The submitted version is directed at the assessing the ability of Hdac2 and Hdac3 deletion to modify both cellular and molecular phenotypes associated with HD. As the authors note, the data hint the Hdac2 deletion modifies HD phenotypes via mechanisms unrelated to CAG expansion. The inability of the data to firmly interpret the relationship between instability and striatal phenotypes detracts from the impact of the current version. All reviewers found the most compelling data to be the impact of HADC loss-of-function on alterations in gene expression associated with HD. Thus, it is critical that the manuscript be revised to focus on HDAC and medium-spiny neuron transcriptional regulation. Perhaps the effect of HADCs on somatic instability would best be presented not as the lead but as a possible mechanism by which dysregulated genes associated with HD are normalized. Likewise, the title should be reconfigured to reflect focus on HDACs and MSN transcriptional dysregulation in HD.</p></disp-quote><p>This was very helpful, and we agree that the manuscript needed to be refocused in a different way. To do this, we have reframed the Introduction to highlight a “two-step” mechanism of HD pathogenesis, supported by recent GWAS studies, invoking both CAG expansion and “cellular toxicity” as two critical components in HD. These two components are separable mechanistically, and therefore can be influenced by different modifiers, or by the same modifier by different mechanisms. However, modifiers of CAG expansion may alter downstream processes that relate to cellular toxicity if there is sufficient sensitivity to detect the effects of somatically expanded repeats (as is the case for nuclear huntingtin pathology phenotypes). This framework therefore does not set up the expectation that effects on transcriptional dysregulation should necessarily be influenced by somatic expansion, but rather that modifier effects can be independent. Our interpretation that these are likely to be independent is in the Discussion.</p><p>At the recommendation of the reviewers we have presented the <italic>Hdac2</italic> KO RNA-seq data first, in order to emphasize these data. This also allows us to better refer back to these data in subsequent sections where we specifically examine expression levels of specific genes, as candidate hypotheses in relation to modifier effects on CAG instability and nuclear huntingtin pathology.</p><p>We have modified the title to specifically include effect on transcription, but also to include other endpoints being measured.</p><disp-quote content-type="editor-comment"><p>2) There is a lack of mechanism provided for the observed molecular changes. The Manuscript proposes a potential mechanism for how HDACs may be contributing to stability by modifying chromatin but do not provide evidence to support this. It is alternatively suggested that KO could affect acetylation of repair proteins. The data presented does not really support this proposed mechanism as there is no change in expression of DDR genes at transcript level and one (MSH3) at the protein level. It would have been helpful to assess levels of unmodified or acetylated MSH2 or MLH1 in the manuscript as these are known modifiers of somatic instability and were suggested in the Discussion. There is a description of an antibody for detecting MSH2 on western blots in the Materials and methods, however this data does not appear in the manuscript nor in the supplement. This could support data on potential mechanisms. Therefore it is recommended to revise the manuscript overall to prioritize the transcriptional normalization that occurs from KD and focus on those molecular insights with reduced focus on the somatic repeat instability piece. At present there is not a direct mechanism on somatic repeat instability and Hdac2 KD and data provided for this possibility in the manuscript would suggest this may not be the case (no changes in DDR genes or levels of MSH3 protein).</p></disp-quote><p>We appreciate that this manuscript does not provide mechanistic insight into the instability modification, and meant only to propose certain hypotheses, rather than specifically favor one over the other. However, as we are able to test mRNA levels of DNA repair genes, we are reasonably able to conclude that <italic>Hdac2</italic> KO does not alter their expression. We followed up on one (MSH3) with a western blot, based on slightly reduced mRNA levels in the RNA-seq data. However, this does not speak to the activity of DNA repair proteins that could be altered by acetylation regardless of their level of expression. Therefore, we would argue that this is still a plausible hypothesis, also indirectly supported in published studies as we indicated. As described above, we have rewritten the manuscript to provide more focus on the RNA-seq component. However, we would like include this speculative part of the discussion as it raises testable hypotheses for future studies. We have made some changes to the text to minimize this section and to clarify the distinction between hypotheses related DNA repair gene expression level and protein activity.</p><p>We have eliminated panel D from Figure 6, as this method of quantification, while of interest generally as a method, did not change the conclusions, and therefore seemed unnecessary with the goal of restructuring the manuscript and reducing some of the instability focus.</p><p>The inclusion of MSH2 in the Materials and methods was a copy-paste error from our previous study and has been removed.</p><disp-quote content-type="editor-comment"><p>3) The methodology regarding how the mice colonies were made and maintained is confusing. Are these mice heterozygous or homozygous for Q111? Perhaps a supplementary breeding scheme diagram? This is vital for data interpretation. Also, please include the Q111 genotype in the main text as well as in the Materials and methods.</p></disp-quote><p>We have modified Figure 1 with a schematic to broadly illustrate the crosses. This now better sets up the experiment, together with the immunohistochemistry for <italic>Hdac2</italic> and <italic>Hdac3</italic> KO. In remaking this figure, we moved a part of it with data specific for the <italic>Hdac2</italic> KO to a new supplementary figure (Figure 1—figure supplement 2). We also made a new supplementary figure (Figure 1—figure supplement 1) detailing the crosses.</p><p>We have also simplified the nomenclature of the mice, using <italic>Hdac2/3</italic> KO and <italic>Hdac2/3</italic> WT rather than <italic>Hdac2/3</italic><sup>Δ/Δ</sup> and <italic>Hdac2/3</italic><sup>+/+</sup>. The simplified nomenclature represents the combination of <italic>Hdac2/3</italic> and D9-Cre genotypes (as explained in the Materials and methods and shown in Figure 1—figure supplement 1) and is therefore a better way to represent the loss of expression or wild-type expression of HDAC2/3.</p><p>All mice are heterozygous for the <italic>Htt</italic><sup>Q111</sup> allele and we have clarified this throughout the text.</p><disp-quote content-type="editor-comment"><p>4) Presentation of RNAseq data is difficult to follow and not fully described. For instance, it is not clear from the text whether genes that are consistently altered in HD are restored in expression and information on statistical enrichment. Similarly, the comparison with Langfelder et al., data is unclear. Suggest to use graphical visuals representing gene changes and observed overlaps instead of tables or guide readers' eye to specific rows and columns being discussed when referencing figures. Further, suggest adding additional figure references in the fourth paragraph of the subsection “Impact of MSN-specific Hdac2 knockout on the transcriptome” for RNAseq comparisons to make it more clear so to which datasets text is referring to. Finally, conclusions relating to analysis from RNAseq does not appear to be consistent with the data. While the manuscript states that none of the rescued genes met the adjusted p-value cut-off (subsection “A subset of genes dysregulated in Htt<sup>Q111</sup> striata is reversed by knockout of Hdac2 in MSNs”), the author's interpretation of results suggests a rescue effect (subsection “A subset of genes dysregulated in Htt<sup>Q111</sup> striata is reversed by knockout of Hdac2 in MSNs”, last paragraph). Due to the lack of significance, would recommend re-phrasing to a suggested rescue rather than a definite one.</p></disp-quote><p>We have made several changes to better display the data and/or to make them more accessible</p><p>– For the number of DEGs (Figure 2B), we now display the data as graphs rather than tables. For the overlaps between the DEGs and enriched pathways between the different 2-way contrasts, we removed the overlap tables and created a new figure (Figure 3—figure supplement 1) in order to make these tables more visible. In the Results section we refer to the highlighted cells within these tables so that the data can be readily located. We have also defined each of the four 2-way contrasts as contrast 1, 2, 3 and 4 (labeled in Figure 2A), allowing us to refer clearly to these throughout.</p><p>– We have incorporated heat maps in Figure 4 and in Figure 2—figure supplement 4 to better display the data</p><p>Rescue of <italic>Htt</italic><sup>Q111</sup>-dysregulated genes: We have redone these analyses to ask the question in a different and more straightforward way. The way this question was initially addressed was based on relative enrichment of gene dysregulation by <italic>Hdac2</italic> KO in <italic>Htt</italic><sup>Q111</sup> compared to WT with the aim of subtracting a “background effect” of the <italic>Hdac2</italic> KO. However, this does not necessarily allow us to test directly for normalization of absolute gene expression levels.</p><p>We have now performed the following analyses to more directly address the question of gene expression rescue:</p><p>1) We identified genes whose expression levels are not significantly different between wild-type mice and <italic>Htt</italic><sup>Q111</sup> mice harboring the <italic>Hdac2</italic> KO mutation. The results of this analyses are shown in Figure 4. and comprised ~12% of all <italic>Htt</italic><sup>Q111</sup>-dysregulated genes.</p><p>2) As the reviewers point out, relatively few of the <italic>Htt</italic><sup>Q111</sup>-dysregulated genes met a p value significance threshold corrected for multiple testing. We therefore analyzed the set of “common dysregulated genes” determined above in the intersection with the Langfelder data to determine whether these were corrected. These results are shown in Figure 4—figure supplement 1.</p><p>3) It was apparent from the “common dysregulated genes” that, regardless of the absolute effect of the <italic>Hdac2</italic> KO on gene expression, the presence of the KO mutation lessened the impact of the <italic>Htt</italic><sup>Q111</sup> allele relative to the <italic>Htt</italic><sup>+/+</sup> allele. This is essentially what our original analysis had captured, which we focus on now only in the subset of significant “common dysregulated genes”. This is an interesting observation that we have highlighted in Figure 5.</p><p>Lack of statistical significance: We agree that caution is needed with interpretation. In the Results we have used the term “possible rescue” in line with the reviewers’ recommendation. In the Discussion, we also included a sentence highlighting this caveat (Discussion, fourth paragraph). We have now also placed more focus on the significant genes that overlapped with the Langfelder significant genes.</p><disp-quote content-type="editor-comment"><p>5) While the Discussion addresses some of the previous studies investigating HDACs and HDAC inhibitors in HD, this is by no means comprehensive. Studies by Hoshino et al., 2003, and Qunti et al., 2010, should be included discussing HDAC expression in HD human and mouse tissue, respectively. Additionally, work by Jia et al., 2016, Chopra et al., 2016, and Siebzehnrubl et al., 2018, discuss the effects of various HDAC inhibitors on models of HD. Please include these in your Discussion section and also give a brief introduction to this previous work in the Introduction.</p></disp-quote><p>Thank you for pointing out these omissions. We have now included discussion of Jia et al., 2016, Chopra et al., 2016, and Siebzehnrubl et al., 2018, as well as additional studies of HDAC inhibitors in mice in the Discussion in relation to transcriptional dysregulation and nuclear pathology, and included these studies in the Introduction. The work from Hoshino et al., 2003, and Quinti et al., 2010, was not easily incorporated into our Discussion as this detracted from the major points. Therefore, we mentioned these papers in the Results (subsection “Impact of MSN-specific <italic>Hdac2</italic> knockout and of the <italic>Htt</italic><sup>Q111</sup> allele on the transcriptome”, first paragraph) in relation to the observation that the <italic>Htt</italic><sup>Q111</sup> allele did not alter <italic>Hdac</italic> expression, as these studies are directly relevant to this point.</p></body></sub-article></article>